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ABSTRACT 
 
Theiler’s Virus-Induced Apoptosis in Cerebrovascular Endothelial Cells. 
(May 2003) 
Mamatha Somanath Nayak, B.S., Bangalore University; 
M.S., Manipal Academy of Higher Education 
Co-Chairs of Advisory Committee:  Dr. Cristabel J. Welsh 
    Dr. Rita J. Moyes 
 Theiler’s murine encephalomyelitis virus (TMEV) is classified as a cardiovirus 
in the Picornaviridae family.  An enteric virus, TMEV spreads within the mouse 
population by the fecal-oral route.  The neurovirulent GDVII strain of Theiler’s virus 
causes a fatal encephalitis in all strains of mice following intra-cranial infection of the 
virus.  Persistent BeAn strain of Theiler’s virus causes a demyelinating disease in 
susceptible strains of mice, which is similar to the human disease - Multiple Sclerosis 
(MS).   Although a well-recognized model for MS, the route of entry of the virus into the 
central nervous system (CNS) following natural infection has not been well understood.  
One of the proposed portals of entry includes the blood-brain barrier (BBB).  This report 
indicates the ability of both the neurovirulent and the persistent strains of Theiler’s virus 
to induce apoptosis in the functional units of the BBB – the cerebrovascular endothelial 
cells (CVE) both in vitro and in vivo.  Induction of apoptosis in CVE was demonstrated 
by annexin staining, electron microscopy, DNA fragmentation assay, Hoechst staining 
and by caspase-3 staining. Corresponding to results by other authors, GDVII is a 
 iv 
stronger inducer of apoptosis in CVE compared to BeAn.  Induction of apoptosis is 
dependent on the MOI of the virus. UV-inactivated virus is not capable of inducing 
apoptosis and induction of apoptosis appears to be an internal event not requiring 
activation of death receptors.   Determining the pathway of induction of apoptosis by 
TMEV in CVE indicated the involvement of a Ca2+ dependent pathway for apoptosis  
– the calpain pathway.  Involvement of calpain in apoptosis has been reported in MS.  
Induction of apoptosis in CVE in vivo was also demonstrated following the intra-
peritoneal inoculation of Theiler’s virus.  Induction of apoptosis in CVE following 
Theiler’s virus infection could lead to a breach of the BBB and entry of inflammatory 
cells as well as virus into the central nervous system.  This finding could aid 
understanding the neuropathogenesis of Theiler’s virus.   
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CHAPTER I 
 
INTRODUCTION 
 
MULTIPLE SCLEROSIS 
 Multiple Sclerosis (MS) is the most common demyelinating disease of the nervous 
system.  In the US approximately 250,000 individuals suffer from MS, with 10,000 new 
cases reported each year (88).  MS is an inflammatory disease of the central nervous 
system (CNS) white matter characterized by demyelination, focal T cell and macrophage 
infiltration, axonal injury and loss of neurological function.  The pathological features 
consist of white matter (WM) plaques characterized by primary demyelination and death 
of oligodendrocytes within the center of the lesion.  Early in the disease process, the 
blood brain barrier (BBB) is damaged and perivascular inflammatory cells enter the 
CNS and destroy the WM.  Different types of MS exist and the disease is usually 
classified on the basis of the clinical course of the disease.  The five main types of MS 
are (141): 
1. Benign:  This occurs in 10-15% of patients where the disease does not develop 
into the progressive form of the disease.  The symptoms are mild to moderate 
and it does not lead to permanent disability. 
 
_____________________ 
This dissertation follows the style and format of Journal of Virology. 
22. Relapsing-remitting:  About 85% of people with MS begin with this form.  It is
characterized by one or two flare-ups every 1-3 years and this is followed by
periods of remission.  Symptoms worsen with each flare-up.
3. Primary progressive: This occurs in 10% of patients.  From the first appearance of
symptoms, the neurological functions deteriorate without periods of remission.
4. Secondary progressive: Following years of having relapsing-remitting, about half
of the patients will enter a stage of continuous deterioration.
5. Progressive relapsing: This is essentially primary progressive MS with new
episodes worsening the existing ones. This is a very rare form of MS and occurs
in less than 5% of the cases.
MS usually manifests between the ages of 20 and 40 and affects women twice as
often as men (121).  The etiology of MS is largely unknown.  A number of risk factors
have been associated with susceptibility to MS.  These include: race, sex, age, ethnicity,
weather conditions, diet, socio-economic status, family history, migration and genetic
factors.  Among genetic factors, HLA class II genes exert an influence with HLA DR2
carrying a 4-fold relative risk (7).  A further role for genetics is implied in the findings
that in monozygotic twins there is an increased incidence of MS over dizygotic twins
(53).  But genetics alone is not sufficient to predispose to MS.  There appears to be a
complex interplay of more than one risk factor.  There is increasing evidence for the role
of viruses in the development of this disease (6, 15).  MS outbreaks have been reported
3in places such as Faroe Islands in 1950’s following arrival of British troops, strongly
indicating the involvement of an infectious agent (122).  Studies have also suggested that
migration to and from high-risk areas influences the development of the disease (120).
There is also epidemiological evidence of increased risk of MS in persons with a history
of childhood exposure to infectious agents (99).  In addition, relapses in MS appear to
occur following respiratory (54, 181) and gastro-intestinal viral infections (9).  The most
convincing evidence for the role of viruses in the disease process of MS comes from the
reports of elevated serum antibodies to a variety of common viruses such as herpes
simplex virus (HSV), rubella and coronavirus (2, 11, 212, 239).  Paramyxovirus-like
inclusions in MS brains have also been demonstrated by electron microscopy (112).  A
viral etiology has clearly been established in a variety of other human demyelinating
diseases such as subacute sclerosing panencephalitis (SSPE) linked to measles virus
(99), progressive multifocal leukoencephalopathy linked to JC virus (70) and HTLV-1
associated mylopathy/tropical spastic paraparesis (HAM/TSP) (179).
Some of the viruses that have been implicated in the etiology of MS include:
human herpes virus-6 (59, 89), varicella zoster virus (205), vaccinia virus (3), measles
virus (72) (42), canine distemper virus (80),  parainfluenza virus (207), rubella virus
(103) and retroviruses (115, 183). There has been no success in linking MS to a single
virus and there is some speculation that MS could be the result of multiple virus
infections of the CNS.
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MECHANISMS BY WHICH VIRUS DAMAGE COULD OCCUR IN MS 
 The viruses that have been implicated in the etiology of MS could enter the CNS 
via the systemic circulation or through nerves. Once in the brain, the virus may mediate 
damage by any one of the following mechanisms (232).   
1. Direct damage of the cells such as oligodendrocytes by cytolysis.   
2. Viruses may set up a chronic infection of cells or could lead to persistent infection 
of the cells, altering the metabolism of cells such as oligodendrocytes that are 
important in the myelination process.   
3.   Viruses might induce an immune response to a viral antigen and by the process 
of ‘epitope-spreading’ may ultimately mediate the damage of self-components in 
the CNS. 
4.  Viruses could set up an autoimmune reaction against cells in the CNS by a 
process known as ‘molecular mimicry’.   
5. Viruses may lead to apoptosis of infected cells, leading to packaging of virus 
components along with self-components in the surface blebs of the apoptotic 
cells. The presentation of these novel packages to macrophages could lead to 
breakdown in immune tolerance against self-antigens and result in autoimmune 
disease. 
MS PATHOPHYSIOLOGY– THEORETICAL PATHOGENESIS 
 T cells reactive against major constituents of myelin sheath, such as myelin basic 
protein (MBP) and proteolipid protein (PLP), are detected in specimens of peripheral 
blood from normal individuals but this activation is regulated by immunoregulatory 
5mechanisms.  These myelin reactive T cells may become activated in the peripheral
system by certain factors such as microbes, which show similarity to these epitopes by a
process called molecular mimicry.  MBP shows extensive homology to several common
pathogens such influenza virus (219), Epstein-Barr virus (26) and herpes virus (40).
Following peripheral activation, these activated T cells are capable of
transmigrating across the BBB via interactions with several adhesion molecules such as
integrins and members of the immunoglobulin supergene family like CD4.   These
activated T cells also express antigens such as very late antigen (VLA)-4, which helps in
binding to the endothelium (83).  In MS lesions, T cells in the perivascular cuffs express
VLA-4 and blockage of VLA-4 in the autoimmune model of MS- Experimental Allergic
Encephalitis (EAE) prevents development of the disease process (255).  In MS lesions,
the inflamed endothelium expresses MHC class II molecules and vascular adhesion
molecules (VCAMs) (140).
In the CNS, the T cells activate local antigen presenting cells such as microglia
cells and astrocytes, which present peptide and lead to stimulation of the T cell in a
positive feedback loop.  The locally activated T cells then secrete proinflammatory and
cytotoxic factors of the Th1 subtype mostly which recruit macrophages to the site of
damage.  In addition, a critical antibody response is directed against myelin and the
complement cascade is also activated with membrane attack complexes directed against
myelin.  This orchestrated attack against myelin and the myelin forming cells by
macrophages and their products such as TNF-a; B cells and antibodies against myelin
and complement activated complexes, results in damage to myelin surrounding nerves
6and results in areas of demyelination impairing saltatory conduction along the axon and
resulting in the neurological deficits associated with the disease.
ANIMAL MODEL SYSTEMS OF MS
Models for MS fall into two categories: viral and non-viral.  The viral model is
based on the hypothesis that the etiological agent involved in triggering MS is a virus.  It
has the advantage that epidemiological and serum antibody evidence indicates viral
infection as a trigger for this disease (229).  But the main drawback is that no single
virus has been isolated that could be implicated in the etiology of MS.  However, several
virus-induced models in experimental animals have been used to study this disease and
address various questions relating to age, sex, and genetic basis of this disease. Some of
the commonly used viral models for MS include:
1. Theiler’s virus
2. Mouse Hepatitis virus
3. Semliki Forest virus
4. Visna
5. Canine Distemper virus
Of the non-viral models for MS, experimental allergic encephalitis (EAE) is the
most studied model.  In EAE, disease is initiated by extra neural injection of CNS
material or purified CNS antigens emulsified in an appropriate adjuvant.  This model
enables investigators to ask very specific questions regarding the autoimmune
component of the disease.  The other less commonly studied models include injection of
7various chemicals including ethidium bromide, cuprizone and lysolecithin.  These have
been particularly useful in the study of remyelination process in MS.  
THEILER’S VIRUS
Theiler’s murine encephalomyelitis virus (TMEV) is a member of the genus
Cardiovirus in the family Picornaviridae.  It is a single-stranded, non-enveloped, RNA
virus.  The genome of TMEV has been sequenced and infectious clones have been
generated (30, 175). Serological evidence indicates that Mus musculus (house mouse) is
the natural host for the virus, but it is also present in other species of mice, voles and
rats. TMEV was first isolated by Max Theiler in 1930 from the CNS of mice with
spontaneous flaccid paralysis of the hind leg (236). In 1952, Daniels et al. reported
demyelination during TMEV infection (47).  But the model did not gain much
importance until Lipton, in 1975, reported a biphasic disease leading to demyelination
(134). It has remained a very popular model for MS since then.  Modes of infection of
TMEV in its host include intra-cranial, intra-peritoneal and intra-nasal.  TMEV is a
natural enteric pathogen of mice and the incidence of spontaneous paralysis is low, about
1 in 2000.  The rare natural incidence of CNS infection is similar to that seen in MS.  It
remains one of the most popular models for MS for the following reasons:
1. Chronic pathological involvement limited to the CNS white matter.
2. Myelin breakdown is accompanied by mononuclear cell inflammation.
3.  Demyelination results in clinical disease for example spasticity by involvement
of upper motor neuron systems.
4. Myelin breakdown is immune mediated.
85. Disease is under multigenic control with a strong linkage to certain MHC genes.
6. Axonal transection is also observed similar to MS.
TMEV can be divided into two subgroups on the basis of their neurovirulence
properties (Table 1).  The highly neurovirulent strains that comprise of at least 4 isolates:
GDVII, FA, VIE 415HTR, and Ask-1 viruses.  GDVII and FA are the most commonly
studied neurovirulent strains.
2. The less virulent TO strains, represented by DA, BeAn, Yale and WW.
Infection with the neurovirulent strains kills all strains of mice of all ages in a
few days by a fatal polioencephalitis.  The affected areas include hippocampus, cerebral
cortex, basal ganglia, thalamus, brain stem and spinal cord (30, 137). The mice develop a
hunched posture and limb paralysis and rapidly succumb to widespread lytic infection of
neurons. Infection with the TO strains causes a biphasic disease that produces a chronic,
immune-mediated, inflammatory demyelinating disease in susceptible strains of mice,
showing similarity with MS.   SJL/J and CBA mice are susceptible to TMEV infection
and BALB/c and C57BL/6 are resistant (Table 2).  The biphasic disease produced by the
TO strain is well documented.  In the natural course of infection, TMEV replicates in the
gastrointestinal tract of the host and occasionally gains access to the CNS where it
persists for the lifetime of the host.  The route of entry of the virus into the CNS has not
been clearly understood, although it is thought to spread to the CNS via retrograde
axonal transport (146, 199), by transport within infected macrophages (37, 129) or by
replication within the blood brain barrier (BBB) (119, 250, 251, 259).
9      TABLE 1. Characteristics of TMEV subgroups
Neurovirulent subgroup Avirulent subgroup
Representative strains
Plaque size in BHK-21
cells
Disease phenotype caused
Viral persistence
Cell tropism
GDVII, FA
Large
Acute polioencephalitis
No
Neurons
BeAn, DA, WW, Yale
Small
Biphasic: early-acute
polioencephalitis, late-
chronic demyelination
Yes
Neurons, glial cells
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TABLE 2.  Strain differences in susceptibility to TMEV-induced demyelination
Highly susceptibility Intermediate susceptibility Highly resistant
SJL
DBA/1
DBA/2
SWR
PL
P
NZW
C3H
CBA
AKR
A
C57BR
BALB/C
C57BL/6
C57BL/10
C57L
129/J
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In the acute stage of the disease following intra-cranial infection with the TO
strains, there is widespread infection of neurons. This occurs within the 10-12 days
following intra-cranial infection and is characterized by a mild encephalomyelitis (134).
Viral antigens and RNA have been demonstrated in neurons of the gray matter (GM)
(46). There is some infection and destruction of astrocytes involved also, but
oligodendrocytes are not involved in the acute stage of the disease (37, 46). The
inflammation at this stage is largely restricted to the GM. In the resistant mice, like
BALB/c mice, a strong inflammatory response is recruited to the CNS and the virus is
totally cleared in 3-4 weeks.  In the susceptible strains of mice like the SJL/J mice, the
virus titer is reduced greatly, but some still persist reportedly in oligodendrocytes (166,
174), microglia or macrophages (37).  This persistence gives rise to inflammatory
lesions in the white matter (WM), mostly in the spinal cord, but also some in the brain.
This summarizes the chronic stage of the disease in the susceptible mice that develops 1
month after infection and persists for the lifetime of the host.  The distinctive change in
the distribution of the virus as well as inflammatory response from GM to WM has been
well appreciated but not clearly understood.  During this stage, the mice develop a
wobbling gait that develops into weakness in the posterior limbs followed by spastic
paralysis.  In the later stages, there is urinary incontinence and loss of righting reflex
(135). In the chronic stage, the virus is methods such as reverse transcriptase polymerase
chain reaction (RT-PCR) and plaque assay.  The number of infected cells is low but they
are usually present in small foci predominantly in the anterior and lateral columns of the
thoracic part of the cord.  There is extensive inflammation and loss of myelin during this
12
stage.  This stage is characterized by meningeal infiltration; cuffs of mononuclear cells
around blood vessels; and parenchymal infiltration consisting of large numbers of
activated macrophages, T cells (both CD4+ and CD8+) and B cells.  The demyelination
corresponds strongly with the presence of inflammatory response.  There is extensive
loss of myelin around normal appearing axons.  Damage to myelin has been contributed
to several factors, which may act singly or in combination with other factors.
Demyelination may result from direct viral infection and destruction of oligo-
dendrocytes.  TMEV causes lytic infection of oligodendrocytes in culture and during the
chronic stage of infection with TO strains, viral antigens and apoptosis have been
demonstrated in oligodendrocytes (241).  Unlike the acute stage of infection, when
virally infected neurons undergo apoptosis, there is no correlation between the apoptosis
and viral infection in oligodendrocytes.  Viral antigens and RNA have been
demonstrated in oligodendrocytes suggesting a role for viral persistence in the CNS.   In
addition, the immune response may contribute to the demyelination process in numerous
ways.  Immunosuppression at this stage reduces the incidence of the disease.  Time of
administration is crucial as early immunosuppressive therapy might actually be more
harmful as it will allow for excessive replication of the virus(252).
IMMUNE RESPONSE
In response to TO virus infection, virus specific humoral immune response starts
1week post infection and reaches a peak by 2 weeks and may be sustained for the
lifetime of the host (184).  Neutralizing and other virus specific antibodies have been
detected.  B cells and CD8+ cells play an important role initially in viral clearance. Both
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susceptible and resistant strains of mice can be infected with the virus, but only those
that can mount a strong anti-TMEV delayed type hypersensitivity  (DTH) response
develop inflammation and demyelination in the spinal cord WM (36).  Most of the
studies point to a strong role for Th1 type of immune response predominantly in the
development of the chronic stage of the disease.  IgG2a subclass of IgG is found
predominantly in susceptible strains of mice with little IgM antibody detected by day 14-
post infection (32, 184).  IgG2a production may be an in vitro measure of the
preferential stimulation of a Th1 pattern.  CD4+ T cells of the Th1 subset mediate
delayed type hypersensitivity (DTH) and regulates IgG2a production through IFN-g.  T
cell proliferation and DTH appear by 2 weeks post infection and remain elevated for 6
months (36).  Both are specific for TMEV and mediated by CD4+ MHC class II
restricted T cells (36).  There is also definite correlation between onset of demyelination
and development of virus specific T cell response and DTH.  DTH and T cell
proliferation responses in SJL/J mice have been found to be primarily towards VP2 and
specific to VP2 amino acids 70-85.  VP2 70-86 is the immunodominant epitope in SJL/J
mice responsible for immunopathology (61, 62).  Mice mount cell-mediated immunity
and humoral immunity early and decrease the viral titer 1000-10,000 fold but this still
leads to persistence.  Extraneural persistence, however, is not observed.
Susceptibility to viral persistence and chronic disease is genetic and it has been
linked to a number of loci including major histocompatibility complex (MHC) H2D loci
(36, 197); T cell receptor b-chain (155); Interferon-gamma (IFN-g) (23, 29); carbonic
anhydrase (156) and myelin basic protein (MBP) genes (23).  Other factors such as sex,
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age, stress and/or other infections in addition to dosage and strain of the virus may be
predisposing factors (107, 199, 231).  The brain-derived TO are more virulent than the
tissue-adapted virus.  TMEV are capable of infecting many cell types of numerous
species including insect cell lines, but are capable of inducing demyelination only in
mice.
DETERMINANTS OF NEUROVIRULENCE AND PERSISTENCE
A considerable amount of work has gone into understanding the differences
between the persistent and the neurovirulent strains of Theiler’s virus in order to address
their differences in pathogenesis.  TO strains lead to the persistence of the virus in
various cell types. In the acute stage of the disease process, viral antigens have been
demonstrated in neurons and astrocytes (24, 198, 241).  During the early stages of the
chronic disease, viral antigens have been demonstrated in macrophages, astrocytes and
oligodendrocytes.  In the later stages of the chronic phase, the distribution of virus is
confined mainly to oligodendrocytes (241). GDVII causes fatal encephalitis and the
virus is seen to cause lytic infection only in neurons.  In the rare survivors of this
encephalitic process, the virus does not persist in any cell type. The complete nucleotide
sequences of representative strains for both TMEV subtypes are known and infectious
cDNA clones of both viruses are available.  BeAn and GDVII are 90.4% identical at the
nucleotide level and 95.7% identical at the amino acid level (175, 188, 189).  The
changes are dispersed all along the genome.  The most differences occur at the 5’ end.
The 3’ end is more or less conserved between all groups within Picornaviridae.  The 5’
non-coding region of picornaviruses may have a number of functions relating to
15
secondary structure, which may in turn control viral RNA synthesis, initiation of
translation, encapsidation, and virion uncoating.  Hence this region may be very
important in pathogenesis.  Based on numerous investigations, a number of genomic
regions and gene products have been postulated to influence virulence.  Studies by
Jnaoui and Michiels (97) suggest that GDVII and BeAn utilize partly distinct pathways
for both entry into cells and genome replication and have suggested a major role for
receptors in the pathogenesis of the two viruses.  The role for receptors in the pathogenic
process of the two viruses should not to be discounted.  Several analyses of recombinant
TMEVs have mapped persistence determinants to the capsid suggesting a role for a
virus-receptor interaction in persistent infections.  Several authors have shown that the
two viruses utilize different mechanisms to enter a single cell line (58, 97).  Low
virulence BeAn and DA have been shown to use cell surface sialic acid as an attachment
factor (257), while GDVII does not require sialic acid. Sialic acid plays an important
role not just in cell entry but also in TMEV persistence and demyelinating disease (257).
Outside the CNS, peripheral nerve protein PO has been suggested as a TMEV entry
receptor (131).  Very recently, Reddi and Lipton (192) reported that the highly
neurovirulent GDVII utilizes heparan sulfate as an attachment factor.   Both viruses have
been postulated to utilize UDP-galactose transporter for cell entry and infection (78).
This might be of importance as UGT locus lies very close to the clinical disease marker
D11Mit179 on chromosome 11(12).   The broad tropism of DA suggests either the use
of several receptors or one receptor that is highly homologous across species.
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Recombinant viruses constructed by exchanging corresponding genomic regions
between the highly virulent GDVII and the less virulent BeAn or DA viruses has shed
light on the role of these genomic regions and the role of the capsid proteins.   But
Lipton reports that attenuation of neurovirulence of GDVII was not sufficient to produce
a persistent infection (30, 136).  These results were confirmed by Jarousse et al. (91)
where the neurovirulence of GDVII was attenuated by insertion in the 5’ region.  This
still did not yield a persistent strain of virus.
Some of the earliest work regarding capsid proteins and their role in virulence or
persistence had been done by McAllister et al.  (151) and it was suggested that
persistence and demyelination map to the regions coding for VP1 capsid protein.  Recent
work by Adami et al. (1) confirms these findings and the regions involved in persistence
have been further mapped to VP2 puff and the VP1 loop regions. These results were
confirmed by Wada et al. (247) by exchanging the Loop II of VP1 of DA strain with the
Loop II of GDVII and this altered persistence and demyelination.   VP1 and VP2 had
earlier been reported to play an important role in viral persistence (257).
The evidence for a role of an out of frame protein – L* protein in persistence of
the TO strains has been highly compelling.  L* is a protein produced in only the TO
strains as a result of an alternative, out of frame initiation site.  In GDVII, the AUG is
changed to ACG, which can very rarely serve as an initiation codon too.  Several studies
did with mutations in this gene yield conflicting results.  DAL*-1 with a mutation
introduced in the L* region, is no longer able to persist and this suggests a strong role for
this protein in viral persistence (63).  But the introduction of L* into GDVII does not
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convert it to a persistent strain, but only enhanced the infection of macrophages by
GDVII (245).  Recent studies by Obuchi et al.  (169) show the association of the protein
with microtubules in infected cells suggesting its further role in pathogenesis and
persistence.  L* has also been postulated to play an important role by inhibition of the
antivirus cytolytic T cell activity that normally clears the virus in the acute stage of the
infection (133).  L* facilitates the growth of the virus in monocyte or macrophage cell
lines (170, 245).  In addition, L* has anti-apoptotic activity (63).
Interestingly, reports by Michiels et al. (158) and others suggest that GDVII and
BeAn did not evolve as two separate groups, but that GDVII potentially evolved from
TO strains by losing some of their persistence characteristics to become a more virulent
strain. There has been speculation that a difference in expression of viral polymerases
might account for viral persistence.  GDVII was reported to express more viral
polymerases in the cells that it infects in the CNS, while during the chronic phase
infection with BeAn, there was very little viral polymerase expression in the infected
cells, though viral proteins could be demonstrated in them (104).
BLOOD BRAIN BARRIER
In the natural infection, TMEV replicates in the gastrointestinal tract of the host
and occasionally gains access to the CNS where it persists for the lifetime of the host.
The route of entry of the virus into the CNS has not be clearly understood, although it is
thought to spread to the CNS via retrograde axonal transport, by transport within
infected macrophages or by replication within the blood brain barrier (BBB).  The BBB
is composed of specialized cerebrovascular endothelial cells (CVE).  On the abluminal
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side of the CVE are astrocytes with associated pericytes, perivascular macrophages and
fibroblasts.  The BBB plays an important role in maintaining the immunologically
privileged nature of the CNS, although alterations in the BBB allow the entrance of
immune cells into the CNS.  In CNS inflammatory diseases, like MS and TVID, the
BBB is disrupted during an early stage of the disease process, and immune cells,
particularly the T cells traverse the BBB, enter the CNS and mediate demyelination.
The disruption of the BBB seems to be a crucial event in the development of the disease.
Viral antigens have been detected early in the TVID in CVE and this may play a role in
the development of the disease (259).  In addition a number of viruses have been shown
to penetrate the BBB by replication within the CVE (99, 102).  Interestingly many of the
viruses implicated in the etiology of MS or shown to cause demyelination in animals
also infect CVE (100, 101).
The BBB is formed by specialized CVE that line the lumen of the blood vessels.
The endothelial cells have relatively few pinocytic vesicles and a high resistance
(1900units/cm2), features that contribute to the limited permeability of the BBB.  In
addition, they have very little MHC expression unlike endothelial cells that supply other
organs.  In most inflammatory conditions of the CNS like MS and TMEV, lymphocyte
cuffing is observed around post capillary venules and this suggests that the main route of
cellular migration (and viral migration in case of TVID) may occur across the BBB.
Heterotrophic brain transplants from susceptible (SJL/J) to resistant mouse
strains suggest that regulation of susceptibility to disease resides at the level of cerebral
endothelium and not within the CNS parenchyma or lymphoid/bone marrow-derived
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compartment.  Therefore, the interactions that occur at the BBB are critical in the
development of inflammatory CNS disease.
A role for BBB in the disease process of MS is suggested by the fact that BBB
dysfunction is associated with relapses in MS.  In addition, BBB dysfunction has been
reported to be an initial event in the development of MS lesions.  Elevation of soluble
adhesion molecules (218) and the role of nitric oxide (66, 214) in endothelial cells has
been well documented in MS and strongly suggests a role for BBB in the disease
process.  Antibodies to CVE were detected in MS patients and rhesus monkeys injected
with CVE were shown to develop EAE.  In patients with MS, therapy with IFN-g caused
exacerbations, which may have resulted from increased MHC class II expression on
CVE. And subsequently, antigen presentation, which would allow increased access of T
cells into the CNS.  Interestingly, cytotoxic activity against CVE has also been described
in MS patients (235, 240).
 A number of viruses that induce demyelination have been shown to infect the
CVE. Vascular endothelial cell damage has been documented in hemorrhagic fever
viruses (13), human immunodeficiency virus (HIV) (33) and measles virus (41).
Therefore, the BBB may play a very important role in the viral infection of the CNS.
CVE possess many specialized receptors that may function as viral receptors (68).
Infection of the CVE may allow for the virus to gain access to the CNS or may result in
up-regulation of expression of various molecules involved in lymphocyte adhesion
(228).  Several viruses are also able to replicate in the CVE and destroy them thus
causing a breach in the BBB allowing the entry of more virus and inflammatory cells
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into the CNS (13, 144). During virus infection of CVE, damage to the BBB may be due
to virus replication, virus induced cytopathic effects or anti-endothelial cells antibodies.
Very recently HIV (220), Influenza virus (85) and SIV (4) have been demonstrated to
induce apoptosis in CVE thus causing damage in the BBB.  In TVID, CNS endothelial
cells have been demonstrated to contain viral nucleic acid.  Also, enhanced MHC class II
expression has been found during TMEV infection suggesting a role for CVE in TMEV
infection (250, 251).  There is strong evidence to suggest that TMEV may enter the CNS
by infection of the CVE.  CVE are permissive to TMEV replication both in vitro and in
vivo.
VIRAL INFECTIONS OF THE CNS
Neurotropic viruses follow two basic pathways to gain access to the CNS:
(i) neuronal pathway and (ii) hematogenous pathway.  Rabies virus (124) and Herpes
simplex virus (HSV) (145) are the prototype of virus infection of the CNS through
peripheral neuronal spread.  A few other viruses such as poliovirus (195) and reovirus
(57, 162) that had earlier been thought to spread through the hematogenous route have
now been shown to spread via peripheral neurons in experimental animals.  The main
nerves involved in this spread are peripheral and cranial nerves (163).  Rabies spreads
via myoneural infection.  In the case of HSV, cranial nerves such as olfactory and
trigeminal nerves play a crucial role in the transport of the virus to the CNS (163).  The
olfactory nerve is particularly unique in it that the olfactory neurons are not protected by
the BBB and therefore provide a direct neuronal access to the brain.
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In the case of the hematogenous spread, enterovirus and arboviruses are the
prototype of viremic spread to the CNS.  These viruses have to overcome several
barriers before gaining access to the CNS.  The first and the most important criteria is
that the virus must bypass or attach to and enter a host epithelial cell.  This cell must be
permissive to the virus. The first signs of infection involve replication at the site of entry
and a transient viremia.  Infection of secondary tissue usually ensues.  Most frequently,
there is a spread to the lymph nodes or they can bypass this and enter the circulatory
system and seed other tissues. Arboviruses, enteroviruses, measles virus and varicella
virus follow this mode of spread and seed in a variety of other organs such as liver and
spleen (102).  A local immune response at this point can curtail the spread of most
viruses.   Some viruses can, however, resist phagolysosomal degradation and then use
the macrophages to circulate and replicate within.
Some viruses such as human rhinovirus, influenza virus and poliovirus have
developed unique abilities to escape the immune system.  These viruses have their
receptors embedded in pits or ‘canyons’ in the viral membrane thus enabling them to
evade the immune response (82, 127).
The primary viremia seeds the virus to distant locations. In neonatal HSV, virus
infection of the CNS follows primary viremia.  Virus must localize in the vessels of the
CNS before crossing the BBB or the blood-CSF barrier.  The virus can enter the CNS by
either one of the following ways; by infection and replication within the CVE, by
leaking across a damaged CVE, by passive channeling through the CVE (pinocytosis or
colloidal transport) or by bridging endothelial cells within migrating leucocytes (233,
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253). Either cell-associated or cell-free virus can cross the endothelial cells and enter the
parenchyma or CSF.
APOPTOSIS
Apoptosis, or programmed cell death, has recently gained immense importance
due to its role in neural development and in a wide variety of neurological diseases
including viral infections.  The term ‘apoptosis’ is derived from a Greek word and it
implies leaves falling from a tree.  It was coined in 1972 by Kerr, Currie and Wyllie to
describe the common morphological changes that characterize the process of cellular
self-destruction (110).  It is a naturally occurring process and its importance has been
recognized in embryogenesis, maintenance of homeostasis, normal cell turnover,
induction and maintenance of immune tolerance and development of the nervous system.
Apoptosis is an active, energy-requiring process, which requires the synthesis of
a series of proteins.  In apoptosis, there is an orderly execution of death signals that
ultimately results in the death of the cell, which is usually phagocytosed by a
macrophage.  This helps limiting the inflammatory response and results in very specific
macrophage mediated removal of the apoptotic cell and remnants.  Another form of cell
death from which apoptosis needs to be differentiated is necrosis, which is caspase-
independent, lacks DNA fragmentation and there is no formation of apoptotic bodies
(Table 3).  This results in leakage of intracellular contents to neighboring tissue and
results in the elicitation of a huge inflammatory response Macrophages recognize
apoptotic bodies that express phosphotidylserine and other surface molecules with the
help of receptors such as CD14, scavenger receptors and integrins (157).
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TABLE 3. Differential features and significance of necrosis and apoptosis
Apoptosis Necrosis
Morphological Features
Loss of membrane integrity
Begins with swelling of cytoplasm and
mitochondria
Ends with total cell lysis
Disintegration of organelles
Biochemical Features
Loss of regulation of ion homeostasis
No energy requirement
Random digestion of DNA (smear of DNA
after agarose gel electrophoresis)
Morphological Features
Membrane blebbing but no loss of integrity
Begins with shrinkage of cytoplasm and
condensation of nucleus
Ends with fragmentation of cell into
smaller bodies
Formation of membrane bound vesicles
(apoptotic bodies)
Mitochondria becomes lealy due to pore
formation involving proteins of Bcl-2
Biochemical Features
Tightly regulated process involving
activation and enzymatic steps
Energy dependent active process
Non-random mono- and oligonucleosomal
length fragmentation of DNA (ladder
pattern after agarose gel electrophoresis)
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TABLE 3. (contd)
Apoptosis Necrosis
Post-lytic DNA fragmentation
Physiological Significance
Affects groups of contigious cells
Evoked by non-physiological disturbances
(complement attack, lytic viruses, hypoxia,
metabolic poisons)
Phagocytosis by macrophages
Significant inflammatory response
Pre-lytic DNA fragmentation
Release of various factors (cytochrome-C,
AIF) into cytoplasm by mitochondria
Activation of caspase cascade
Alteration of membrane asummetry
(translocation of phoshotidylserine from
the cytoplasm to the extracellular side of
the membrane)
Physiological Significance
Affects individual cells
Induced by physiological stimuli (lack of
growth factors, changes in hormonal
environment)
Phagocytosis by macrophages of adjacent
cells
No inflammatory response
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Apoptosis can be initiated by various stimuli including viral infection.  The
apoptotic process can be divided into 2 phases: (i) initiation phase, which depends on
apoptosis inducing stimuli (ii) effector phase, common to all specific process.  Both
these phases involve caspases and caspase-3 has a key role in the effector phase.
Caspases are central to the apoptotic process in most cases, but there are some caspase
independent proteases such as calcium activated cysteine protease- calpain and the
ubiquitin dependent proteasome pathway that can play an important role too.  DNA
fragmentation, translocation of PS to the outer side of the cell membrane, morphological
changes are all outcomes of the two phases.  In most cases, the apoptotic cell death
begins 12-24 hrs after the initiating trigger.
A cell undergoes apoptosis following some common conditions such as
withdrawal of positive signals (growth factors for neurons, IL-2); receipt of negative
signals (increased levels of oxidants within the cell, damage to the DNA by UV, X-ray
or chemotherapeutic drugs) or by molecules that bind to receptors and signal death of the
cell (TNF, lymphotoxin, FasL binding to Fas).
The first description of virus-induced apoptosis was the finding that the E1B-19K
mutant of adenovirus induced severe cytopathic effect of the infected cells, accompanied
by a marked decrease in the yield of the progeny virus (190). Similar results were
observed in baculovirus infected insect cell lines and other mutant adenovirus strains
(117).  The effect of apoptosis is time dependent and it may act in favor of the host or in
the favor of the virus.  If the host cell manages to induce apoptosis before the virus has
completed a round of replication, the cell may curtail spread of the virus. In this case,
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some viruses have developed specialized ways of overcoming this by producing anti-
apoptotic products.  However, if there is induction of apoptosis after the virus has
completed a few rounds of replication, this may be beneficial to the virus and aid in
further spread of the virus throughout the system.
A number of DNA and RNA viruses, including varicella-zoster (208), human
immunodeficiency virus (125), coronavirus (20) and reovirus (48), have been reported to
trigger apoptotic cell death.  In contrast, other viruses, such as adenovirus (190),
baculovirus (39), vaccinia virus (60), and Epstein-Barr virus (71), are capable of down-
regulating the apoptotic process to allow for cell survival and continued viral replication.
Poliovirus is unique in its ability to induce apoptosis as well as inhibit the process (238).
The relation between induction of apoptosis and neurovirulence is highly conflicting.
Itoh et al. report that in case of Sendai virus infection, the virulent strain of the virus
causes minimal apoptosis resulting in a high virus titer (86).  Whereas, the avirulent
strain induces apoptosis and this occurs before the virus completes a round of replication
resulting in low virus titers.  In the case of Sindbis virus, which causes fatal encephalitis
in neonatal mice, neurovirulence has been associated with apoptosis (130, 243).
Interestingly, virus-induced apoptosis can occur by different mechanisms in
insect and in mammalian cell lines.  Apoptosis induced by HIV-1 infection of the CNS
has been well documented. Recent reports have demonstrated apoptosis of neurons,
astrocytes and endothelial cells in HIV-1 infection (220).  Apoptosis of CVE has been
suggested to be an important factor in the development of disease in HIV-1 and
Influenza A virus infection of the CNS (85).
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Virus-induced apoptosis in cells can have a variety of effects.  The most common
one being the induction of cytopathic effects (CPE) in cells.  CPE by viruses results in
disruption of a variety of cell processes such as nucleic acids and proteins, cytoskeletal
architecture and the presence of membrane integrity.  Viruses such as Herpes simplex
virus, HIV, Influenza and Measles virus are capable of inducing CPE by apoptosis (182).
Rosen et al. also suggest that infection with Sindbis virus can lead to an autoimmune
process through the induction of apoptosis (204).  In their classic set of experiments they
indicate that there was distribution of viral antigens in surface blebs of apoptotic cells.
They proposed that this could define a novel immune context for self-antigens.  In the
case of Systemic Lupus Erythematosus (SLE), calreticulin, an endoplasmic reticulum
auto antigen has been shown to form complexes with rubella during virus replication.
These studies strongly suggest that induction of apoptosis could generate novel sources
of concentrated foreign and self-antigens, which could break down tolerance and lead to
autoimmunity.
Recent evidence indicates that apoptosis or programmed cell death plays a very
important role in the development of neurodegenerative diseases such as Alzheimer’s
disease (AD) and Parkinson’s disease (PD) (96, 171, 178).  The role of apoptosis in the
disease process of MS is currently being investigated and there are reports of
oligodendroctye and astrocyte apoptosis in MS (176, 200, 258).  Apoptosis of
oligodendrocytes (241) and neurons (10, 241) has been documented in TVID.  Whether
this plays an important role in the disease progression has yet to be determined.
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TMEV AND APOPTOSIS
TMEV from both neurovirulence groups have been shown to induce apoptosis
both in vitro and in vivo.  Whether this is important in the pathogenesis of the virus has
yet to be determined.  Tsunoda et al., showed that in the acute disease by both GDVII
and DA, there is induction of apoptosis of neurons (241).  The induction of apoptosis by
GDVII could possibly explain the development of fatal encephalitis by this strain.  At
this stage, viral antigens co-localize with neurons undergoing apoptosis (241).  It is
postulated that reduced apoptosis or survival of neurons in DA may be due to apoptosis
inhibiting molecules.  Ghadge et al. showed the role of L* - an out of frame protein, in
the persistence of DA (63).  GDVII lacks L* and is more efficient at inducing apoptosis
on permissive BHK21 and restrictive macrophages.  L* appears to play a very crucial
role in persistence as DA L*, a mutant that lacks L* now shows characteristics very
similar to GDVII (245).  L* has anti apoptotic properties adding credence to the fact that
persistence might be linked to a greater ability to inhibit apoptosis by the persistent
strains of TMEV (63).
Extensive experimentation indicates that GDVII is more capable than the TO
strains in inducing apoptosis (95, 173, 241).  Both restrictive as well as permissive cells
undergo apoptosis on infection with GDVII and BeAn in vitro (10, 92-95).  During the
acute phase of the disease by GDVII and TO, apoptotic neurons are detected and there is
co-localization of the viral antigen and apoptotic cells indicating, induction of apoptosis
to be a more direct effect of the virus and less of external factors (241).  But during the
chronic stage in TO infection, the scene appears to be different.  The sites of viral
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persistence during the late demyelinating phase have yet to be resolved.  Astrocytes,
oligodendrocytes and macrophages all carry a major viral load and undergo apoptosis.
There appears to be a lack of co-localization of viral antigen in these cells and induction
of apoptosis indicating the involvement of soluble factors in apoptosis.  Apoptosis
induced in the neurons during the acute phase might follow a different pattern than
during the chronic stage of TO infection.  In oligodendrocytes, it is postulated that nitric
oxide (87, 177, 203), cytokines and chemokines might play a role (111).  Reduction of
demyelination in SJL/J mice treated with TGFB2 shows the role of soluble mediators in
TMEV infection (50).  TGFB2 reduces demyelination by reducing macrophage
dependent apoptosis though TGFB2 did not directly reduce TMEV.  A role for nitric
oxide in TMEV infection further implies the role for soluble factors in the induction of
apoptosis.  Increased level of nitric oxide leads to necrosis and low levels of nitric oxide
leads to apoptosis in neurons.  Inhibition of nitric oxide by amino guanidine (AG)
reduced apoptosis but AG did not have anti-viral effect (203).  This indicates the role of
soluble factors and other elements of the immune system in the chronic stage of the
disease.
BeAn and GDVII can both induce apoptosis in restrictive cells and permissive
cells.  But GDVII is 50 times more capable of inducing apoptosis in restrictive cells.  It
was earlier believed that TMEV was capable of inducing apoptosis only in restrictive
cell lines and not in permissive cell lines, but studies on cerebellar explant culture of
neurons have demonstrated that permissive cells also undergo apoptosis (10).  In some
cells, such as macrophage cell lines, the stage of differentiation determines whether the
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cell can undergo apoptosis induced by TMEV (92).  Myeloid precursor cell line M1 is
protected from apoptosis by TMEV, whereas the differentiated M1D cells undergo
apoptosis.  Whether the state of differentiation of cells is important in the induction of
apoptosis needs further verification in other cell lines.  Difference in the induction of
apoptosis in M1 and M1D cells has been linked to increased Bcl-2 expression in M1
cells than M1D.  Also, M1D shows increased expression of pro-apoptotic proteins bax
and bak.
The pathway of induction of apoptosis in cells infected by TMEV has only been
partly identified.  The pathway may be different in various cell types.  However, there is
compelling evidence that apoptosis is an intrinsic mechanism.  UV-inactivation of
TMEV leads to decreased apoptosis in various cell types (95).  Recent studies have
indicated that in a macrophage cell line, BeAn induces caspase-3 dependent apoptosis
(94).  The other proteins involved are TRAIL and TNF-a.  The same studies have also
shown that over-expression of Bcl-2 had no effect on cell viability or caspase-3
production.
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HYPOTHESIS 
The hypothesis tested in this dissertation is that TMEV is capable of 
inducing apoptosis in CVE and this may play a crucial role in the disruption of the 
BBB.  GDVII is more effective in inducing apoptosis in the CVE and hence may be 
responsible for the fatal encephalitis in all strains of mice.  BeAn, in contrast, shows 
reduced ability to induce apoptosis in CVE as compared to GDVII and this may 
account for the ability of BeAn strain to establish a persistent infection in cells.  The 
differential induction of apoptosis by the two strains may account for the difference 
in their neurovirulence properties.  
 Experimentally addressing the mechanisms involved in the induction of 
apoptosis in CVE by TMEV may provide insights into the neuropathogenesis of 
Theiler’s virus.  Induction of apoptosis in CVE by TMEV was assessed by a variety of 
methods.   
Specific questions addressed were: 
- Differences between induction of apoptosis in CVE by neurovirulent and 
neuropersistent strains of TMEV 
- Correlation between induction of apoptosis and cytopathic effects of the virus 
- Dependence of induction of apoptosis on the MOI of the virus 
- Pathway of apoptosis involved in the induction of apoptosis 
- Correlation between in vitro and in vivo findings 
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CHAPTER II 
 
INDUCTION OF APOPTOSIS IN CLONED MOUSE CEREBROVASCULAR 
ENDOTHELIAL CELLS FOLLOWING TMEV INFECTION 
 
INTRODUCTION 
Multiple Sclerosis (MS) is one of the most common demyelinating diseases 
affecting 250,000 individuals in the US alone (88).  The etiology of MS is largely 
unknown, but epidemiological evidence suggests it to be an acquired environmental, 
possibly, viral disease (6).  Several viruses have been implicated in the etiology of MS.  
One of the prominent features of MS is the breakdown of the blood brain barrier (BBB) 
early in the disease process (109).  The BBB is responsible for maintaining the 
immunologically privileged nature of the central nervous system (CNS)(18, 90) and is 
composed of specialized cerebrovascular endothelial cells (CVE).   Many viruses have 
been shown to enter the CNS following infection of the CVE (Johnson 1982).  
Interestingly, many of the viruses implicated in the etiology of MS or shown to cause 
demyelination in animals also infect CVE (6, 105, 113).   
Theiler’s-virus induced demyelination (TVID) serves as a relevant model for 
MS.  Theiler’s murine encephalomyelitis virus (TMEV) is an RNA virus belonging to 
the genus Cardiovirus in the Picornaviridae family.  They are divided into 2 subgroups 
on the basis of their neurovirulence properties; (i) neurovirulent strains, represented by  
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GDVII and FA, cause a fatal encephalitis in all strains of mice and (ii) persistent TO
strains, represented by BeAn and DA, cause a biphasic disease leading to demyelination
in susceptible strains of mice.  TMEV naturally infects the gastrointestinal tract of mice
and occasionally gains access to the central nervous system (CNS) where it establishes a
persistent infection.
The route of entry of TMEV into the CNS has not been determined.   Some of
the proposed portals of entry include (i) through infected macrophages (37, 129); (ii)
retrograde axonal transport (146, 199) or (iii) by replication in the cells of the blood
brain barrier (BBB)(119, 250, 251, 259). CNS endothelial cells have been demonstrated
to contain viral nucleic acid in nude mice infected with TMEV (259).  Also, enhanced
MHC II expression has been found during TVID in vivo suggesting a role for CVE in
TMEV infection (202).  CVE are permissive to TMEV replication both in vitro (119,
251) and in vivo (259) and there is strong evidence to suggest that TMEV may enter the
CNS by infection of the CVE.  Infection of the CVE may allow the virus to gain access
to the CNS and/or may result in the up regulation of expression of various molecules
involved in lymphocyte adhesion.
In addition to infecting the CVE, several viruses are capable of inducing
apoptosis.  A number of DNA and RNA viruses have been reported to trigger apoptotic
cell death in a variety of cell types.  Several members of the Picornaviridae family such
as Coxsackie virus B3 (31), Hepatitis A virus (22), Avian encephalomyelitis virus (138),
Enterovirus 71(118) and Polio virus (8, 44, 139) are also capable of inducing apoptosis.
Polio virus is unique in its ability to both induce apoptosis as well as prevent apoptosis
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(238).  In the case of Sindbis virus, which causes fatal encephalitis in neonatal mice,
increased neurovirulence has been associated with apoptosis (130).   Recent reports have
demonstrated apoptosis of the neurons, astrocytes and endothelial cells in Human
Immunodeficiency virus (HIV-1) infection (220).  Apoptosis of CVE has been suggested
to be an important factor in the development of disease in HIV-1 (33, 220), Simian
Immunodefeciency virus (SIV)(4) and Influenza A virus (85) infection of the CNS.
TMEV from both neurovirulence groups have been shown to induce apoptosis both in
vitro (10, 92-95) and in vivo (241).  A number of cells including macrophages,
astrocytes, neurons and oligodendroctyes have been documented to undergo apoptosis
during TMEV infection (10, 92, 95, 180, 241).
The aim of the present study was to study the induction of apoptosis in cloned
mouse CVE derived from two strains of mice (SJL/J – prototype strain susceptible to
TVID and BALB/c – prototype strain resistant to TVID).  Induction of apoptosis in the
CVE was studied following infection with GDVII and BeAn strains of Theiler’s virus by
a variety of methods in order to determine whether neurovirulence correlated with
increased levels of apoptosis.
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MATERIALS AND METHODS
Virus
The BeAn 8386 strain and GDVII were obtained from Dr. Howard L. Lipton
(Northwestern University, Evanston, IL).  The virus was grown in BHK-21 cells, and the
culture supernatant containing infectious virus was aliquoted and stored at -70C before
use.  The viral titer was determined by plaque assay on BHK-21 cells (206).
Cell culture
CVE that have been isolated from brain microvessels of either TVID-susceptible (SJL/J)
or resistant (BALB/c) mice were used in these experiments.  CVE were isolated and
cloned by limiting dilution as described previously (213).  These cells remain diploid
and maintain their differentiation markers in culture.  Frozen aliquots were thawed and
grown in Iscove’s Modified Dulbecco’s Medium (IMDM)(GIBCO BRL, New York,
NY) supplemented with 10% fetal bovine serum (FBS) (Atlanta Biologicals, Norcross,
GA), 2mM glutamine (GIBCO BRL, New York, NY), 100units/ml Penicillin and
100mg/ml Streptomycin (GIBCO BRL, New York, NY) at 37°C and 4%CO2.
Infection of CVE
SJL/J and BALB/c CVE were grown in IMDM supplemented with 10% FBS for growth
and 1% FBS for post inoculation maintenance of cell cultures.  For infection with virus,
the CVE were grown to confluence in T 25 flasks and infected with BeAn and GDVII
strains of Theiler’s virus at a MOI of 1.   The viruses were allowed to adsorb for 45 min
at room temperature and were subsequently washed with IMDM and further incubated in
IMDM with 1% FBS.  Control cells were treated similarly but without the addition of
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the virus.  The cells were resuspended using Trypsin and EDTA at the required time
points and utilized for the respective assays.
UV-inactivation of the virus
Inactivation of both BeAn and GDVII was carried out by exposing previously titered
virus infected BHK cell lysates to the UV illuminator lamp (1330mW/cc) at a distance of
13cm for 30 min. UV-inactivation of the virus was confirmed by performing plaque
assay.
Annexin assay
The translocation of phosphotidylserine from the inner side of the plasma membrane to
the outer layer is an early apoptotic plasma membrane alteration.  After the respective
treatment with either virus, the CVE were stained with the Annexin V-FLUOS staining
kit (Boehringer Mannheim, Indianapolis, IN) and quantified by fluorescence activated
cell sorter (FACS Calibur, Becton Dickinson, San Jose, CA).  The staining was
performed as per the manufacturer’s recommendations.  The proportion of cells stained
by propidium iodide (indicating necrosis), Annexin V (indicating apoptosis), or both
(late stages of apoptosis) was determined using an Epics Coulter cytometer (Becton
Dickinson, San Jose, CA).
LSCR analysis
Cells prepared by the method above were also analyzed by the Laser Scanning
Cytometer (LSCR system).  10ml of each sample at a concentration of 1x106 cells/ml
were utilized for LSCR analysis.  The LSCR utilizes an argon laser operating at 5mW.
The cell detection threshold was set to select single cells based on forward angle scatter
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integral.  Cells from the region determined were electronically gated to a dot plot of
Annexin V integral versus PI integral.  Cells were gated based on Annexin V staining
and PI staining.  Cells from each region were sorted and plotted by Compu SortTM.
Electron microscopy
SJL/J and BALB/c CVE were infected with BeAn and GDVII as previously described.
At 18h and 24h post infection, the cells were harvested, pelleted by low speed
centrifugation (1,000 rpm for 10 min) and fixed in 2% paraformaldehyde, 2%
gluteraldehdye fixative in 0.2 M Cacodylate buffer.  After primary fixation, cells were
pelleted, suspended in 1% osmium tetroxide, dehydrated in a series of 75-100% ethanol
and propylene oxide and embedded in epoxy resin.  Ultra thin sections were prepared in
a Sorvall MT 2B ultramicrotome, stained with lead citrate uranyl acetate, and examined
using a Zeiss 10C electron microscope.
DNA laddering
At the appropriate time points post infection, the DNA was extracted from 1x106 mock
infected and virus infected CVE using Trizol reagent (Invitrogen, Carlsbad, CA)
according to the manufacturer’s directions.  The extracted DNA was precipitated with
ethanol, dissolved in TE and 1mg of DNA was digested at 37°C for 15min with 1 U of
DNase-free RNase (Promega, Madison, WI).  DNA fragments were resolved by agarose
gel electrophoresis and stained with Syber Gold (Molecular Probes, Eugene, OR) to
visualize fragmented DNA.
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DNA.Hoechst, mitochondrial activity and caspase-3 staining 
Monolayers of CVE cells grown on glass coverslips were mock-infected or infected with 
BeAn or GDVII at MOI of 1.  At different times p.i., cells were washed in PBS and 
stained with the appropriate dyes.  
Hoechst staining 
Hoechst 33342 is a vital DNA stain that binds preferentially to A-T base pairs.   Cells 
undergoing apoptosis can be visualized showing cell shrinkage and chromatin 
condensation.  The cells following infection were treated with 5µM of cell-permeable 
Hoechst 33342 (Molecular Probes, Eugene, OR) for 15 min in the dark, mounted on 
slides in IMDM and visualized under fluorescence microscope. For Hoechst 33342, the 
excitation was 340-380 nm and the emission filter was 465 nm. Multiple cells were 
inspected randomly, and only representative fields are presented in the figures.  
Mitochondrial activity staining 
The accumulation of tetramethylrhodamine methyl and ethyl esters in mitochondria and 
the endoplasmic reticulum has also been shown to be driven by their membrane 
potential.  Tetramethylrhodamine, methyl ester, perchlorate (TMRM) has been used to 
measure mitochondrial depolarization related to cytosolic Ca2+ transients and to image 
time-dependent mitochondrial membrane potentials.  At different times p.i., cells were 
washed in PBS and stained with 1.5 nM tetramethylrhodamine methyl ester (TMRM) 
(Molecular Probes, Eugene, OR) for 30 min at 37C and washed twice with phosphate 
buffered saline (PBS) (187). Images were acquired with a fluorescence microscope.  For 
TMRM, the excitation was 568 nm and the emission filter was 590-640 nm. Multiple 
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cells were inspected randomly, and only representative fields are presented in the
figures.
Caspase-3 staining
Rhodamine 110, bis-L-aspartic acid amide (R-22122) (Molecular Probes, Eugene, OR)
contains rhodamine fluorophore flanked by aspartic acid residues and serves as a
proteinase substrate for caspase-3.  At different time points, the cells are stained with
Rhodamine 110, bis-L-aspartic acid amide at 37C for 30 min in the dark.   For Rhodamine
110, the excitation was 498 nm and the emission filter was 521 nm. Multiple cells were
inspected randomly, and only representative fields are presented in the figures.
Caspase inhibitors
Inhibition of caspase activation was conducted using the pan caspase inhibitor-
benzyloxycarbonyl-Val-Ala-Asp fluoromethylketone (ZVAD.FMK) (BIOMOL,
Plymouth meeting, PA).  zVAD.FMK at concentration of 100mM has been shown to
inhibit caspase activity completely in cultured mammalian cells (226).  Mock infected and
BeAn infected cells at 90% confluency were treated with 100mM of zVAD.FMK  for 1h
prior to infection with the virus. Following viral infection, 100mM zVAD.FMK was added
to the media.  The cells were stained for Hoechst staining as described above following
24h of infection.
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RESULTS
Serum deprivation induces apoptosis in CVE
The translocation of phosphotidyl-serine (PS) is one of the earliest markers for apoptosis
and we recorded apoptosis using the staining of PS by Annexin V.  Firstly, the induction
of apoptosis in CVE due to serum deprivation was determined by growth of CVE in
media containing decreasing amounts of FBS. Serum deprivation has been shown to be a
strong signal for apoptosis in other cell cultures (52, 108).  CVE were grown in media
containing 0%, 1%, 5% and 10% of FBS and induction of apoptosis was recorded.
There was some induction of apoptosis in CVE upon serum deprivation (Fig. 1).
BALB/c CVE was more affected by serum deprivation than SJL/J CVE.  CVE infected
with either strain of Theiler’s virus were incubated in media with 1% of FBS.  The
induction of apoptosis at this concentration of FBS was minimal and did not affect our
readings.
Increasing MOI of the virus, increases CPE and apoptosis
Different authors use varying titers of virus for infection depending on the cell type. In
order to determine the appropriate MOI for our studies on induction of apoptosis, SJL/J
and BALB/c CVE were infected with BeAn and GDVII at increasing MOI (0.1, 1, and
10) for 24h p.i and the effects on apoptosis and CPE were recorded.  Apoptosis was
determined by Annexin V and CPE was recorded using a light microscope. Figures 2
and 3 indicate that increasing MOI shows increasing CPE and increased apoptosis.
These results suggested the use of MOI of 1 for all our further studies.  Virus at this MOI
did not greatly induce apoptosis or cause increased CPE.
41
FIG. 1.  Effect of serum deprivation on the induction of apoptosis in
CVE. SJL/J and BALB/c CVE were treated with 10%, 5%, 1% and no
serum for 24h and  induction of apoptosis was analyzed by AnnexinV-PI
staining.  During viral infection, CVE were treated with 1% serum.  This
level of serum deprivation only caused minimal effects of apoptosis.
0
0.5
1
1.5
2
2.5
3
3.5
10% 5% 1% no serum
%
 A
po
pt
os
is SJL/J
BALB/c
42
A
C D
B
0
0.5
1
1.5
2
2.5
3
3.5
control 0.1 1 10
%
A
po
pt
os
is
FIG. 2.  Increasing MOI of BeAn increases CPE and apoptosis. Light
microscopy (40X) of mock-infected SJL/J CVE (A) or SJL/J CVE  infected with
BeAn at MOI 0.1 (B), 1 (C) or 10 (D). (E) indicates Annexin V staining of CVE
treated with increasing MOI of BeAn.
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FIG. 3.  Increasing MOI of GDVII increases CPE and
apoptosis.  Light microscopy (40X) of mock-infected SJL/J CVE
(A) or SJL/J CVE infected with GDVII at MOI 0.1 (B), 1 (C) or 10
(D). (E) indicates Annexin V staining of CVE treated with
increasing MOI of GDVII.
 44 
UV-inactivation of BeAn and GDVII reduces the ability of Theiler’s virus to induce 
apoptosis 
To determine whether the pro-apoptotic effect of BeAn and GDVII was receptor 
mediated or it required viral replication, we determined induction of apoptosis in SJL/J 
and BALB /c CVE following infection with UV-inactivated BeAn and GDVII. The UV-
inactivation procedure was confirmed by plaque assay, which did not yield any plaques.  
Figure 4 indicates that UV-inactivation of BeAn and GDVII reduced the ability of the 
viruses to induce apoptosis as recorded by Annexin V assay.  
Annexin V analysis of BeAn and GDVII induced apoptosis of SJL/J and BALB/c 
CVE 
SJL/J and BALB/c CVE were infected with BeAn and GDVII at MOI of 1 and sampled 
at the following time points: 12h, 18h, 24h and 48 h.  The induction of apoptosis was 
recorded by Annexin V assay.  Figure 5 shows an increasing trend in the induction of 
apoptosis over time by infection of both CVE with BeAn and GDVII. There was 
minimal induction of apoptosis at 12h, but by 18h there was definite induction of 
apoptosis. It is interesting to note in figure 6 that at 24h, majority of the cells are in the 
apoptotic quadrant but by 48h, most of the cells have moved into the necrosis/late 
apoptosis quadrant indicating secondary necrosis. Figures 7 and 8 confirm these results. 
These findings were further confirmed by microscopic analysis of Annexin V stained 
cells using the Laser Scanning cytometer.  Apoptotic cells stain green and necrotic cells 
stain red due to PI.  Figure 9 shows cells early in apoptosis staining with Annexin alone 
and cells late in apoptosis stain with both Annexin and PI, indicating secondary necrosis. 
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FIG. 4.  Annexin V staining of CVE infected with UV-
inactivated TMEV.  SJL/J CVE and BALB/c CVE were infected
with UV-inactivated BeAn and GDVII at MOI of 1 for 24h.   Note
that UV-inactivation of the virus reduces the ability of the virus to
induce apoptosis.   The above figure is representative of three
independent experiments.
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FIG. 5.  Annexin V staining of TMEV-infected CVE (24h).  SJL/J
CVE and BALB/c CVE were infected with BeAn and GDVII at MOI of 1
for 24h.   Note that both BeAn and GDVII were capable of inducing
apoptosis but GDVII was a more potent inducer of apoptosis.  The above
figure is representative of three independent experiments.
0
10
20
30
40
50
60
70
80
90
100
control BeAn GDVII
%
 A
po
pt
os
is
SJL/J
BALB/c
47
P
I
ANNEXIN V
B
DC
A
FIG. 6.  Flow cytometry analysis of TMEV-infected SJL/J CVE (24h).
SJL/J CVE were either mock-infected (B) or infected with BeAn (C) or GDVII
(D) at MOI of 1 for 24 h and stained with Annexin V and PI as described in
materials and methods.  (A) represents distribution of cells following staining
with the two dyes.  Following infection with TMEV, most cells move rapidly
into the quadrant that denotes secondary necrosis/necrosis.
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FIG. 7.  Annexin V staining of TMEV-infected CVE (48h).  SJL/J
and BALB/c CVE were infected with BeAn and GDVII at MOI of 1
for 48h.  Note that for BeAn infected CVE, more cells are apoptotic
compared to 24h.  GDVII was more apoptotic as compared to BeAn.
The above figure is a representative of three independent
experiments.
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FIG. 8.  Flow cytometry analysis of TMEV-infected BALB/c CVE
(24h). BALB/c CVE were either mock-infected (B) or infected with BeAn
(C) or GDVII (D) at MOI of 1 for 24 h and stained with Annexin V and PI
as described in materials and methods.  (A) represents distribution of cells
following staining with the two dyes.  Following infection with TMEV,
most cells move rapidly into the quadrant that denotes secondary
necrosis/necrosis.
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FIG. 9.  Annexin V and PI staining of CVE infected with TMEV.
Photomicrographs of SJL/J CVE infected with BeAn at MOI of 1 for 24h pi,
sorted by Laser scanning cytometer.  (A) shows cells in the initial stages of
apoptosis that stain with Annexin V alone.  (B) shows cells in the late stage of
apoptosis, possibly indicating secondary necrosis, that stain with both
Annexin V and PI.
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Hoechst, caspase-3 and mitochondrial activity staining following infection of CVE 
with BeAn and GDVII  
The morphology of apoptotic cells was further confirmed using Hoechst staining.  SJL/J 
and BALB/c CVE were grown on cover slips and at the appropriate time points post-
infection, the cells were washed and stained with Hoechst stain, caspase-3 stain and 
TMRM. Figure 10 indicates, increasing induction of apoptosis by BeAn and GDVII in 
SJL/J CVE over time. Mock-infected CVE displayed very minimal signs of apoptosis 
only at 48h. Hoechst staining indicative of nuclear involvement in the development of 
apoptotic process can be seen by 18h p.i.  Apoptotic nuclei can clearly be demonstrated 
by nuclear condensation. The percentage of apoptotic nuclei in both CVE infected with 
BeAn and GDVII increases over time and ultimately clumps of cells that have been 
dislodged due to cytopathic effects (CPE) can be seen comprising apoptotic nuclei (Fig.  
11). Thus, we can infer that CPE and apoptosis may be closely linked.  TMRM staining 
indicates strong mitochondrial activity prior to induction of apoptosis as determined by 
Hoechst staining (Fig. 12).  This starts at 12h p.i and is reduced by 24h p.i when 
apoptotic nuclei can be demonstrated.  Caspase-3 activity can be demonstrated as early 
as 3h p.i following viral infection of the CVE.  No caspase-3 activity was observed in 
mock-infected cells.  Caspase-3 activity appears to be one of the earliest apoptosis-
related events in CVE infected with TMEV (Fig. 13).  GDVII infection did not cause 
heightened activity of caspase-3, or show increased Hoechst staining as compared to 
BeAn infected CVE.   
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FIG. 10.  Morphological changes in TMEV-infected SJL/J CVE. SJL/J 
CVE were grown on glass cover-slips and mock- infected (A) or infected with
BeAn (B) or GDVII (C) at MOI of 1 for 24h pi and stained with Hoechst 
33342 to observe nuclear changes.  Nuclear condensation and cell shrinkage 
can be clearly observed in BeAn and GDVII infected CVE.  
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FIG.11.  Induction of apoptosis and cytopathic effects 
are correlated. SJL/J CVE infected with BeAn at MOI 
of 1 for 24h was stained by Hoechst 33342.  Clumps of 
cells dislodged due to cytopathic effects of the virus 
contained numerous apoptotic nuclei.
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FIG. 12.  Mitochondrial activity changes in TMEV-infected SJL/J
CVE.  SJL/J CVE were grown on glass cover-slips and mock-infected
(A) or infected with BeAn (B) or GDVII (C) at MOI of 1 for 18h pi and
stained with TMRM and Hoeschst 333 42 to observe mitochondrial
activity changes as well as nuclear  changes. Mitochondrial activity (red)
can be observed prior to nuclear changes in TMEV infected CVE. A few
cells showing nuclear condensation (blue) can be observed in BeAn and
GDVII infected CVE. .
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FIG. 13.  Caspase-3 activity in TMEV-infected SJL/J CVE.  SJL/J CVE
were grown on glass cover slips and mock-infected (A) or infected with
BeAn at MOI of 1 for 3h and stained with Rhodamine 110 to detect
Caspase-3 activity.  There was an increase in Caspase-3 activity only in
BeAn infected CVE as shown by the green fluorescence.
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DNA fragmentation assay
DNA oligonucleosomal laddering is one of the hallmarks of apoptosis and is one of the
ultimate steps in the death of the cell by apoptosis.  Figure 14 shows that BeAn and
GDVII infected SJL/J CVE show DNA fragmentation at 24h and 48h.  There is no DNA
fragmentation observed in mock- infected CVE.  It is interesting to note that in addition
to DNA laddering a smearing pattern is observed, indicating possibly secondary
necrosis.
Electron microscopic analysis of apoptosis
Induction of apoptosis in SJL/J and BALB/c CVE infected with BeAn and GDVII was
observed ultramicroscopically (Figs. 15 and 16).  Electron microscopic analysis
confirms the induction of apoptosis in CVE infected with Theiler’s virus.  The CVE
were infected with BeAn and GDVII at MOI of 1 for 24h.  At 24h, mock-infected CVE
do not show considerable signs of apoptosis.  Uninfected BALB/c CVE show some
initial signs of apotosis with minimal nuclear margination.  This observation corresponds
to the Annexin V data, which indicates BALB/c CVE show slight signs of apotosis upon
serum deprivation. Infection of both CVE with BeAn shows classical signs of apoptosis
as is indicated by surface blebbing, nuclear margination and condensation and loss of
organelles. Infection with GDVII shows heightened signs of apoptosis with nuclear
condensation, loss of organelles and even appearance of apoptotic bodies.  This shows
signs of secondary necrosis, which correspond to the data from the Annexin assay.
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FIG. 14.  DNA laddering in TMEV-infected SJL/J
CVE.   SJL/J CVE were either mock infected or
infected with BeAn or GDVII at MOI of 1.  At 48h pi,
DNA was extracted, processed and subsequently 1 µg
of extracted DNA was analyzed by electrophoresis in
a 1.5% agarose gel as described in materials and
methods.  DNA laddering was observed only in BeAn
and GDVII infected CVE.
SJ
L
/J
 C
on
 4
8 
h
B
1.6KB
1.0KB
0.5K
SJ
L
/J
 G
D
V
II
 4
8 
h
SJ
L
/J
 B
eA
n 
48
 h
 58 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A
C
FIG. 15.  Ultramicroscopic details of TMEV-infected SJL/J CVE. Electron 
micrographs of mock-infected SJL/J CVE  (A) (5000Xmagnification) and 
SJL/J infected with BeAn (B) (6300X magnification) or GDVII (C) (5000X 
magnification) at MOI of 1 for 24 h pi.  Cells were fixed and processed as 
described in materials and methods.  Nuclear and cellular abnormalities, 
characteristic of apoptosis, are observed in CVE infected with BeAn and 
GDVII only.  These changes include nuclear condensation, loss of organelles 
and surface blebs (*).  Bar represents 1µm.
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FIG. 16.  Ultramicroscopic details of TMEV infected BALB/c CVE.
Electron  micrographs of mock-infected BALB/c CVE (A) (6300X
magnification) and BALB/c CVE infected with BeAn (B) (5000X
magnification) or GDVII (C) (5000X magnification) at MOI of 1 for 24h pi.
Cells were fixed and processed as described in materials and methods.
Nuclear and cellular abnormalities characteristic of apoptosis are observed in
CVE infected with BeAn and GDVII only.  These changes include nuclear
condensation, loss of organelles and surface blebs (*).  Mock-infected
BALB/c CVE appear to undergo some level of apoptosis following serum
deprivation. Bar represents 1mm.
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DISCUSSION
Experiments described in this report demonstrate the induction of apoptosis in
cloned mouse CVE derived from two different strains of mice following infection with
TMEV.  This is the first report of apoptosis in CVE following infection with TMEV.
Apoptosis induction was similar in both types of CVE.  Theiler’s virus from both
virulence groups have been reported to induce apoptosis in a variety of cells both in vivo
and in vitro.  Whether the induction of apoptosis is important in the pathogenesis of the
virus has yet to be determined. Following intracranial infection with TMEV, a variety of
cells including neurons (10, 241), oligodendrocytes (241), macrophages and astrocytes
have been postulated to carry a major viral load and to undergo apoptosis.  TMEV is
capable of inducing apoptosis in both permissive as well as restrictive cells. GDVII has
been shown to induce more apoptosis than the TO strains, thus indicating that
neurovirulence can be associated with increased apoptosis. This could account for the
fatal polioencephalitis following GDVII infection intracranially.  The role for anti-
apoptotic proteins has been postulated in TO strains, which could lead to persistence.  L*
- an out of frame protein is found in DA and not in GDVII and it has been reported to
have anti-apoptotic features (63).
In our study, we have shown that infection of CVE from two genetically different
strains of mice, with TMEV, resulted in the induction of apoptosis.  This induction of
apoptosis was dose dependent and required replicating virus.  Increasing the MOI of the
virus showed increasing CPE and increasing effect on apoptosis suggesting a strong link
between the two.  Further, Hoechst staining of CVE confirmed this finding.  Floating
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cells that were dislodged by CPE showed clumps of highly apoptotic cell.  Hence,
similar to other viruses, we can infer that CPE in CVE is directly related to apoptosis.
UV-inactivation of the virus did not result in apoptosis indicating that apoptosis
was not receptor mediated and there did not appear to be a role for death related
receptors. Similar findings have been reported with TMEV infection of macrophages,
where UV-inactivated virus failed to induce apoptosis.  Complete removal of serum
from the medium signaled for some apoptosis, but the low percentage of serum (1%)
during viral infection procedures did not greatly affect induction of apoptosis by TMEV.
It is interesting to note that BALB/c CVE were more susceptible to apoptosis following
serum deprivation than SJL/J CVE.  This could also be clearly recognized by electron
microscopy.  Following serum deprivation, BALB/c CVE shows some initial signs of
apoptosis.
Earlier studies by Welsh (251) have shown that CVE are permissive to TMEV
and resulting viral titers are comparable to those from BHK-21 cells.  GDVII showed a
very slight increase in CPE compared to BeAn.  Our studies in this report confirm these
findings.  CVE are permissive to TMEV infection and yield infectious progeny
following infection for 8hr.  An MOI of 1 was selected for our studies since this low
infection would be more physiological.  In addition, MOI of 1 seemed the appropriate
MOI as it did not rapidly cause apoptosis and allowed for the observation of onset of
apoptosis over time. At this MOI, there were signs of apoptosis at 18h p.i.  There were
very few signs of apoptosis in BALB/c or SJL/J CVE prior to 18h p.i. and this was
confirmed by Annexin V, Hoescht staining and EM.  However, there is caspase
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activation as early as 3h and also mitochondrial activation as early as 3h. The results
from Hoechst staining coupled with mitochondrial staining, strongly suggests the
mitochondrial activation of CVE prior to induction of apoptosis.  Apoptosis is an energy
requiring procedure and the results confirm this.  Following induction of apoptosis there
is decreased mitochondrial activity.
A number of other neurotropic viruses replicate in the CVE and can mediate
damage.  Infection of CVE may promote damage both directly as well as indirectly.
Some of the viruses that can replicate productively in endothelial cells of the CNS both
in vivo and in vitro are SIV (144), Measles virus (41), Canine distemper virus (14),
Semliki Forest virus (SFV) (228).  In the case of Theiler’s virus, oral infection of
neonatal mice suggests route of entry of TV is through the BBB (73).
TMEV is a natural enteric pathogen of mice and the incidence of spontaneous
paralysis is low. In the natural course of infection, TMEV replicates in the gastro-
intestinal tract of mice and it occasionally gains access to the CNS where it sets up a
persistent infection.  It has been hypothesized that BBB could serve as an important
entry site for the virus into the CNS.    Alterations in the BBB could allow the entrance
of inflammatory cells into the CNS, which would then mediate the damage associated
with TVID.  The disruption of the BBB seems to be a crucial event in the development
of CNS inflammatory disorders like MS.  Both in MS and TVID, the BBB is disrupted
during the early stage of the disease and BBB dysfunction has been associated with
relapses in MS. Very recent reports confirm the involvement of the BBB. The leakage of
serum proteins into extravascular spaces in the brain has been reported by many studies
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(28, 123), indicating BBB dysfunction.   There is increased expression of adhesion
molecules such as ICAM-1 and VCAM-1 on patients with active MS (64, 65), (76). In a
recent report there is some speculation about the role of apoptosis of CVE in the
development of the disease. Minagar et al. (159), report that there is an increase in the
levels of plasma microendothelial particles in MS.  These have been hypothesized to be
vesicles of endothelial cells that have been shed by apoptosis. In addition, in MS and in
TVID, lymophocytic cuffing is observed around post-capillary venules and this suggests
that the main route of cellular migration may occur across the BBB.  Viral antigens have
been detected early in TVID in the CVE (259) and this infection of CVE may play a
very crucial role in the development of the disease.  It is also interesting that many of the
viruses that have been implicated in the etiology of MS or shown to cause demyelination
in animals also infect CVE.  CVE possess many specialized receptors that may function
as viral receptors.  Infection of CVE could result in many outcomes such as upregulation
of various molecules involved in lymphocyte adhesion, or the direct infection of CVE
could result in apoptosis leading to a breach in the BBB.
Apoptosis of CVE has been suggested to be an important factor in the
development of disease in HIV-1 (33, 220), SIV (4) and Influenza A virus (85) infection
of the CNS. Apoptosis of endothelial cells of other organs have been reported in
conditions such as acute lung damage, systemic sclerosis, and as a complication of non-
ionizing radiation.  In culture, apoptosis of CVE can be induced by bilirubin (5) and oxy-
hemoglobin (152, 153).
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Our findings demonstrate that Theiler’s virus induces of apoptosis in vitro in 
CVE.  The induction of apoptosis is dependent on the MOI of the virus, involves the 
activation of caspase-3 and also there is a correlation between CPE and the ability of the 
virus to induce apoptosis.  Like in other cell lines, GDVII is capable of inducing 
increased apoptosis in CVE as compared to BeAn.  These findings may hold importance 
in terms of the pathogenesis of the virus and CNS invasion.  Induction of apoptosis in 
CVE in vivo following systemic circulation could provide a route of entry for the virus 
viruses as well as inflammatory cells into the CNS.  
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CHAPTER III
CALPAIN INVOLVEMENT IN TMEV-INDUCED APOPTOSIS OF CVE
INTRODUCTION
Apoptosis or programmed cell death is a form of physiological cell death
characterized by the sequential activation of a series of proteins that ultimately leads to the
death of the cell.  The hallmarks of apoptosis include DNA condensation in the nuclei,
DNA fragmentation at the nucleosome linkage regions, plasma membrane blebbing, cell
shrinkage and the ultimate formation of apoptotic bodies, which are phagocytosed by
macrophages without eliciting an inflammatory response (55, 216, 246).  Apoptosis is a
process required for normal development of multicellular eukaryotes and is required by
processes such as elimination of self-reactive T cells in the thymus.  However, the
inappropriate initiation of apoptosis is thought to contribute to the etiology of several
pathologies, including neurodegenerative disorders and autoimmune diseases, such as
Type 1diabetes (150).
A variety of viruses are capable of provoking apoptotic cell death.  Neurotropic
RNA viruses that have been associated with apoptosis in vivo include human
immunodeficiency virus (HIV) (186), dengue virus (49), sindbis virus (128), reovirus
(168), poliovirus (67), and Theiler’s murine encephalomyelitis virus (TMEV) (241).
Other members of Picornaviridae family that induce apoptosis in cell culture include
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coxsackie B3 virus (31), hepatitis A virus (22).  Poliovirus is unique in its ability to induce 
as well as inhibit apoptosis (238).  Most RNA viruses do not carry anti-apoptotic genes, 
with the exception of poliovirus, and they usually induce apoptosis in the cells they infect 
and escape deleterious effects by rapid multiplication. 
 Theiler’s murine encephalomyelitis virus (TMEV) is a RNA virus belonging to the 
Picornavirdae family.  Like other members of this family, it is also capable of inducing 
apoptosis.  TMEV is a commonly used animal model for the human disorder- Multiple 
Sclerosis (MS).  In mice, following intra-cranial (i.c) injection, the virus has been shown 
to induce apoptosis in a variety of cell types including neurons, oligodendrocytes, and 
astrocytes (241).   TMEV can induce apoptosis in vitro in differentiated macrophages (92), 
simian kidney cells - BSC-1 cells (95) and neurons (10, 241).  The neurovirulent strain of 
the virus – GDVII, causes fatal encephalitis in all strains of mice is postulated to act 
through the rapid induction of apoptosis in the cell types infected.  The role for an anti-
apoptotic protein- L* protein has been implied in the persistence of the TO strains of 
TMEV (63).  The pathway for induction of apoptosis following TMEV infection has not 
been completely understood, though a role for TRAIL (94) has been suggested in 
macrophages infected with TMEV in vitro.  Caspases are central to most apoptotic 
pathways following infection with viruses, but several other proteases can also play a role. 
This includes a calcium-induced neutral cysteine protease, calpain, which has been 
reported to be unregulated in MS (17, 223) as well as the autoimmune model for MS- 
experimental allergic encephalitis (EAE) (221, 222, 224).   
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The route of entry of TMEV into the central nervous system (CNS) following
natural enteric infection is uncertain.  One of the proposed portals of entry includes
invasion of the blood-brain barrier (BBB) by infection of the cerebrovascular endothelial
cells (CVE) (119, 250, 251, 259).  Several other viruses such as HIV 1 (33), Simian
Immunodeficiency virus (SIV) (4), measles virus (41), Semliki forest virus (SFV) (56)
enter the CNS through this route.  HIV (220) and SIV (4) have been reported to induce
apoptosis in the CVE and thus allow for the breakdown of the BBB.  TMEV is capable of
infecting CVE in vitro (119, 251) and also inducing MHC II (251) expression thus
suggesting a role for these cells in the invasion of the CNS by TMEV.
Previous data demonstrate the ability of both neurovirulent and neuropersistent
strains of TMEV to induce apoptosis in cloned mouse CVE derived from TVID-
susceptible (SJL/J) as well as TVID-resistant (BALB/c) strains of mice. Like other
picornaviruses, TMEV induces cytopathic effects in the CVE and previous work indicates
that the induction of apoptosis and cytopathic effects may be related.  There appears to be
a dose dependent relation for the virus to induce apoptosis and like many other viruses,
UV-inactivation does not induce apoptosis in CVE.
The aim of the following study was to delineate the pathway of apoptosis in CVE
following infection with TMEV in vitro.  The pro-apoptotic protein profile was studied
and questions regarding difference in the abilities of GDVII and BeAn to induce apoptosis
were addressed.  In addition, a role for Calpain in the induction of apoptosis in CVE
following TMEV infection was studied.
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MATERIALS AND METHODS
Virus
The BeAn 8386 strain and GDVII were obtained from Dr. Howard L. Lipton
(Northwestern University, Evanston, IL).  The virus was grown in BHK-21 cells, and the
culture supernatant containing infectious virus was aliquoted and stored at -70C before
use.  The viral titer was determined by plaque assay on BHK-21 cells (206).
Cell culture
CVE that have been isolated from brain microvessels of either TVID-susceptible (SJL/J)
or resistant (BALB/c) mice were used in these experiments.  These cells were isolated
and cloned by limiting dilution as described previously (213).  These CVE remain
diploid and maintain their differentiation markers in culture.  Frozen aliquots were
thawed and grown in Iscove’s Modified Dulbecco’s Medium (IMDM)(GIBCO BRL,
New York, NY) supplemented with 10% fetal bovine serum (FBS) (Atlanta Biologicals,
Norcross, GA), 2mM glutamine (GIBCO BRL, New York, NY), 100units/ml Penicillin
and 100mg/ml Streptomycin (GIBCO BRL, New York, NY) at 37°C and 4%CO2.
Infection of CVE
SJL/J and BALB/c CVE were grown in IMDM supplemented with 10% FBS for growth
and 1% FBS for post inoculation maintenance of cell cultures.  For infection with virus,
the CVE were grown to confluence in T 25 flasks and infected with BeAn and GDVII
strains of Theiler’s virus at a MOI of 1.   The virus were allowed to adsorb for 45 min at
room temperature and were subsequently washed with IMDM and further incubated in
IMDM with 1% FBS.  Control cells were treated similarly but without the addition of
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the virus.  Cell suspensions were prepared by Trypsin/EDTA (GIBCO BRL, New York,
NY) treatment at the required time points and utilized for the respective assays.
UV-inactivation of the viruses
Inactivation of both BeAn and GDVII was carried out by exposing previously titered
virus infected BHK cell lysates to the UV illuminator lamp (1330mW/cc) at a distance of
13cm for 30 min.  UV-inactivation of the virus was confirmed by performing plaque
assay.
RNase Protection Assay (RPA)
RNA was isolated from the infected cells and controls using the Trizol reagent (Life
Technologies, Grand Island, NY) according to the manufacturer’s instructions.  The
RiboQuant multiprobe RNase protection assay (RPA) (Pharmingen, San Diego, CA) was
used to analyze the RNA expression of caspase-8, FASL, FAS, FADD, TRAIL, TRADD
and RIP, using the mAPO-3 template from Pharmingen.  The probe was synthesized
using [a32P] UTP.
Western blot analysis of apoptosis related proteins
The expression of pro-apoptotic proteins was assessed by Western blotting.  Virus
infection of SJL/J and BALB/c CVE were done as previously described.  After the
respective time points, the cells were lysed in a buffer containing 50 mMTris-HCl (pH
7.5), 150mM sodium chloride; and 0.5%NP-40.  Lysates were micro-centrifuged at 4°C
for 10 min, and the supernatants were stored at -20°C.  Protein concentration was
determined by the Bio-Rad protein assay.  Equal amounts of the total protein (20mg)
were then resolved on an 8-15% polyacrylamide gel depending on the requirement and
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transferred to a Hybond-C nitrocellulose membrane (Amersham Biosciences, England)
by semi-dry blotting.  The membrane was blocked with Tris-buffered saline containing
5% non-fat dry milk and 0.02%Tween 20.  This was then incubated with affinity
purified rabbit anti-active caspase-3 monoclonal antibody (1:2000)(BD Pharmingen, San
Diego, CA); purified mouse anti-human PARP monoclonal antibody (1:2000) (BD
Pharmingen, San Diego, CA); mouse monoclonal anti-FAS antibody (1:500)
(Transduction Laboratories, Lexington, KY), mouse monoclonal RIP antibody (1:500)
(Transduction laboratories, Lexington, KY), mouse anti-calpain 1 Large subunit
monoclonal antibody (1:1000)(Chemicon, Temecula, CA), anti-a-fodrin monoclonal
antibody (1:1000)(ICN, Aurora, OH). The expression of these proteins was detected by
ECL according to the manufacturer’s (Amersham Biosciences, England) instructions.
Jurkat cell total protein lysate (Biomol, Plymouth meeting, PA) served as the size-
fractionated positive control.
Intracellular free calcium assay
SJL/J CVE were grown to 70% confluence in 6-well plates and later infected with BeAn
and GDVII at MOI of 1.  Following the appropriate incubation time post-infection, the
plates were washed twice with IMDM.  The cells were then incubated in 1ml IMDM
containing cell permeable fluo 3-acetoxymethyl ester (fluo-3) (Molecular Probes,
Eugene, OR) as fluorescent calcium indicator at a final concentration of 10mM.  The
plates were then incubated at 37C with 5% CO2 for 1h.  The wells were then washed
twice with IMDM and replaced with 1ml IMDM.  The plates were then read on a
fluorometer with fluorescence for fluo 3-acetoxymethyl ester measured with filters for
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excitation at 485 nm and emission at 538 nm.  Relative cell counts were performed using 
staining with Janus Green.  Briefly the procedure for staining was as follows: The cells 
were washed twice with IMDM and incubated in 1ml ethanol for 90 sec.  Following 
drying for 3 min, 1 ml of Janus Green stain was added to the cells and incubated for 1 
min.  The cells were then washed twice with 1X PBS.  500µl ethanol and 500µl PBS 
were added to each well and the plate was read on the fluorometer with absorbance at 
645nm. 
RESULTS 
Caspase-3 activation following TMEV infection of SJL/J and BALB/c CVE 
Following infection of SJL/J and BALB/c CVE with BeAn and GDVII over time points 
12h, 18h and 24h post-infection, cleavage of the zymogen caspase-3 to its pro-enzyme 
form can be observed (Fig. 17).  The zymogen is cleaved over time following infection 
and by 24h, the cleavage is complete.  Earlier results demonstrate that caspase-3 activity 
is started as early as 3h. 
PARP cleavage following TMEV infection 
Poly (ADP) ribose polymerase (PARP) is a nuclear substrate for caspase-3 and several 
other proteases including calpain.  Active PARP exists as a 119kDa protein in the 
nucleus and cleavage of PARP is downstream of caspase-3 activation.  Following 
cleavage by caspase-3, PARP is degraded to an 89kDa protein (126).  However, recent 
reports indicate that PARP can be degraded by other proteases such as calpain. Calpain 
degradation of PARP yields fragments, which are 70kDa to 40kDa (211, 217).  The 
cleavage pattern shown in fig. 18, indicates cleavage of PARP by proteases other than  
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FIG. 17. Caspase-3 activation in TMEV-infected CVE. Pro-caspase
(32kDa) is activated by its conversion to active caspase-3 (17kDa). SJL/J 
and BALB/c CVE were either mock infected or infected with BeAn or 
GDVII at MOI of 1 for the indicated times and immunoblotted with 
antibody to caspase-3 (A).  (B) indicates densitometric analysis of caspase-
3 activity.
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FIG. 18.  PARP cleavage in TMEV-infected CVE.  The 116kDa intact form of 
PARP is broken down to 89kDa only in treated Jurkat cells.  Following infection 
of CVE with TMEV, PARP is broken down to 70kDa cleavage fragments.  SJL/J 
CVE were either mock-infected or infected with BeAn or GDVII at MOI of 1 for 
the indicated times and immunoblotted with antibody to PARP (A).  (B) indicates 
the densitometric analysis of PARP cleavage.
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caspase-3.  Mock-infected CVE do not undergo PARP degradation and PARP 
degradation in CVE infected with BeAn or GDVII appears to increase at 18h post-
infection.  By 48h, PARP is totally degraded and even the 70kDa protein in further 
degraded.   
RNase protection assay for surface-related apoptotic molecules 
RNA isolated from CVE infected with TMEV was analyzed for difference in mRNA 
expression in surface-related apoptotic proteins. Figure 19 indicates there is no 
upregulation of any of these genes following TMEV infection and this is confirmed by 
fig. 20.  In the previous chapter we have shown that following infection with UV-
inactivated virus, there was no induction of apoptosis suggesting apoptosis was an 
intrinsic effect and not the result of the involvement of death receptors.  However, 
TRAIL has been suggested to mediate apoptosis in IFN-γ treated macrophages infected 
with TMEV (94).   
Western blot analysis of Fas and RIP  
To confirm the RPA findings, protein was isolated following TMEV infection of SJL/J 
and BALB/c CVE for various time points and the protein expression of these surface-
related apoptotic proteins were determined.  Interestingly, following TMEV infection, 
Fas expression appeared to be decreased (Fig. 21).  Similarly, RIP expression was 
reduced compared to mock infected controls (Fig. 22).  Results were comparable with 
both BeAn and GDVII.  This was unique but confirmed the RPA finding that apoptosis 
was an intrinsic mechanism following TMEV infection of CVE in vitro. 
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FIG. 19. RNase protection assay on SJL/J CVE with mAPO-3. The 
expression of death receptors and ligands is not altered following 
infection of SJL/J CVE with BeAn or GDVII. RNase protection assays 
with specific probes for caspase 8, Fas, FADD, FAF, FAP, TRAIL, 
TNFp55, TRADD and RIP genes were performed by using 10 ug total 
RNA extracted from SJL/J CVE after either mock infection or infection 
with BeAn and GDVII at MOI of 1 for the time points indicated. As 
internal controls, the mRNA levels of a ribosomal protein (L32) and 
GAPDH were simultaneously analyzed. As a control, RNA extracted 
from mock-infected SJL/J CVE was examined. To identify the protected 
bands, the probe without RNase treatment was applied as a positive 
control. 
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FIG. 20. Densitometric analysis of RNase protection assay. The expression of
caspase-8, FADD, TNF, RIP, TRADD and TRAIL were compared in mock-infected 
CVE and SJL/J CVE infected with BeAn and GDVII over time points indicated.  At 
18h and 24h of infection with TMEV, the expression of these surface proteins related to 
apoptosis were below the levels of controls or at levels comparable to controls.  
However, at 48h infection with TMEV, there is a slight increase in the levels of 
expression of these surface proteins as compared to controls.  But this change is not 
significant.
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FIG. 21.  FAS expression in TMEV-infected CVE. SJL/J and BALB/c CVE
were either mock-infected or infected with BeAn or GDVII at MOI of 1 for the
indicated times and immunoblotted with antibody to FAS.  FAS (45kDa doublet)
expression is reduced following TMEV infection.
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FIG. 22.  RIP expression in TMEV-infected CVE.  SJL/J and BALB/c 
CVE were either mock- infected or infected with BeAn or GDVII at MOI of 1 
for the indicated times and immunoblotted with antibody to RIP(A).  (B) 
indicates densitometric analysis of RIP expression.  RIP expression is 
decreased following TMEV infection of the CVE for 48h.
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Increase in free intracellular calcium following TMEV infection of CVE 
SJL/J and BALB/c CVE were infected with BeAn and UV-inactivated BeAn for 12h and 
24h periods and the changes in free intracellular calcium levels were determined using 
the calcium sensitive fluorescent dye - fluo 3.  At 12h p.i, in both SJL/J and BALB/c 
CVE, there was no net increase in calcium levels as compared to mock-infected  
CVE.  However, by 24h p.i, there was a sharp increase in calcium levels following 
infection as compared to mock-infected CVE (Figs. 23 and 24). This suggests a role for 
calcium in the apoptotic process and also for calpain, which is mediated through Ca2+.   
µ-calpain activity following infection of SJL/J and BALB/c with TMEV 
Cleavage of µ-calpain from its 80kDa pro-enzyme form to the 76kDa zymogen form is 
indicative of its activation (154, 234).  Following infection of SJL/J CVE and BALB/c 
CVE with BeAn and GDVII for 12h, 18h, and 24h, there was a definite increase in the 
pro-enzyme form of µ-calpain.  The ratio of the 76/80 kDa form of µ-calpain was 
increased significantly reaching a maximum in 24h post-infection (Figs.25 and 26).  The 
cleavage patterns were similar in BeAn and GDVII infected CVE.  Mock-infected 
BALB/c CVE controls appeared to express very little amounts of the two forms and this 
may be related to the fact that BALB/c CVE is more susceptible to induction of 
apoptosis following serum deprivation as compared to SJL/J CVE.  Interestingly, in 
SJL/J CVE, the cleavage of µ-calpain did not appear to start until 24h post-infection.   
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FIG. 23. Levels of free intracellular calcium in SJL/J CVE infected 
with BeAn.  SJL/J CVE was either mock- infected or infected with
BeAn at MOI of 1 for 12h and 24h.  Calcium levels were measured by 
the fluorescent calcium indicator - fluo 3-acetoxymethyl ester.  There is 
no increase in calcium levels at 12h following infection with BeAn. By 
24h, there is a sharp peak in calcium levels in BeAn-infected SJL/J 
CVE.
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FIG. 24.  Levels of free intracellular calcium in BALB/c CVE infected 
with BeAn.  BALB/c CVE was either mock- infected or infected with
BeAn at MOI of 1 for 12h and 24h.  Calcium levels were measured by the 
fluorescent calcium indicator - fluo 3-acetoxymethyl ester.  There is no 
increase in calcium levels at 12h following infection with BeAn. By 24h, 
there is a sharp peak in calcium levels in BeAn-infected BALB/c CVE.
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FIG. 25.  Cleavage of µ -calpain in TMEV-infected SJL/J CVE. SJL/J CVE 
were either mock-infected or infected with BeAn or GDVII for the indicated 
times and immunoblotted with antibody to µ-calpain (A).  (B) indicates that the 
ratio of 76/80 kDa of µ-calpain increased significantly in TMEV-infected CVE.
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FIG. 26.  Cleavage of m-calpain TMEV-infected BALB/c CVE. BALB/c CVE
were either mock-infected or infected with BeAn or GDVII for the indicated times
and immunoblotted with antibody to m-calpain (A).  (B) indicates that the ratio of
76/80 kDa of m-calpain increased significantly in TMEV-infected CVE.
 84 
 
Fodrin cleavage infection of SJL/J and BALB/c with TMEV 
Fodrin is a cytoskeletal component that is degraded by both caspase-3 as well as calpain.  
Degradation by either will give rise to characteristic breakdown products. 280kDa fodrin 
is broken down by caspase-3 to yield a 120kDa fodrin break down product (BDP) and by 
calpain to yield a 150/147 (doublet) kDa fodrin BDP (164) (Fig. 27).  As is shown in fig. 
28, there is increased fodrin cleavage following SJL/J CVE infection of BeAn and 
GDVII for 12h, 18h, and 24h.  The major breakdown products are the calpain BDP and 
the maximum activity is seen at 18h p.i.  Control cells show very little break down 
activity.  There is also some low level of caspase-3 activity seen resulting in the 120kDa 
BDP.  In addition, in BALB/c CVE (Fig. 29), interestingly there is a triplet banding 
pattern reported by other authors seen in the calpain related BDP (16, 196).  This 
banding pattern has not been explained. In BALB/c CVE, there is very little caspase-3 
breakdown of fodrin. Earlier experiments had determined that UV-inactivated virus was 
not capable of inducing apoptosis in CVE.   This was further tested by Western blot 
analysis for fodrin cleavage.  As shown in fig. 30, there is no cleavage of fodrin in 
control or SJL/J CVE treated with UV-inactivated BeAn. 
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BDP 120
FIG. 27.  Fodrin breakdown pattern.  Note that 
both calpain and caspase can break down calpain.
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FIG. 28.  Fodrin cleavage in TMEV-infected SJL/J CVE.  SJL/J CVE was mock-
infected or infected with BeAn and GDVII at MOI of 1 for the indicated times and
immunobotted with antibody to fodrin (A).  (B) indicates an increase in fodrin
cleavage in TMEV-infected CVE starting at 12 h and increasing over time.
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FIG. 29.  Fodrin cleavage in TMEV-infected BALB/c CVE. BALB/c CVE was
mock-infected or infected with BeAn and GDVII at MOI of 1 for the indicated
times and immunobotted with antibody to fodrin (A).  (B) indicates an increase in
fodrin cleavage in TMEV-infected CVE starting at 12 h and increasing over time.
(* triplet banding pattern)
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FIG. 30.  Fodrin cleavage in SJL/J CVE infected with UV-inactivated BeAn.
SJL/J CVE was mock-infected or infected with UV-inactivated BeAn and BeAn at
MOI of 1 for 48 h and immunobotted with antibody to fodrin (A).  (B) indicates
densitometric analysis of fodrin cleavage. No increase in fodrin cleavage was
observed in CVE infected with UV-inactivated BeAn.
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DISCUSSION 
 Several RNA viruses including members of the Picornaviridae family induce 
apoptosis in the cell types they infect.  TMEV is a Picornavirus that is known to induce 
apoptosis in various cell types both in vivo and in vitro.  The pathogenesis of this virus is 
not completely understood and the route of entry of this virus into the CNS following 
natural infection has been pursued but not well defined. The present study, examines the 
pathway of induction of apoptosis in cloned mouse CVE following infection with BeAn 
and GDVII.  Earlier work had demonstrated that following infection of SJL/J and 
BALB/c CVE with BeAn and GDVII, there was induction of apoptosis as measured by 
Annexin V, DNA fragmentation, Hoechst staining and electron microscopy.  The present 
study shows the involvement of caspase-3 in both BeAn and GDVII infection of SJL/J 
and BALB/c CVE.  In addition, a role for calpain - a calcium dependent papain-like 
neutral cysteine protease has been suggested by the findings in this report.   Calpain 
activity appeared to be central to the apoptotic process in the CVE and it had the 
prominent role in the degradation of cytoskeletal elements such as fodrin as well as 
nuclear components such as PARP.  It is still unclear at this point, whether Ca2+ influx 
caused activation of calpain or if it was a downstream effect of caspase-3 activity.  
However, combining results from the earlier chapter with present results, shows that 
caspse-3 activation began as early as 3h post-infection. The virus takes 8h to complete 
one round of replication and so this activation of caspase-3 may be related to host 
activity to prevent spread of the virus.  This is, however, highly speculative and needs 
further experimentation.  Calpain activity does not appear to begin before 18h post-
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infection and may be a late effect of caspase-3 activation.  Infection of CVE with UV-
inactivated virus does not induce any apoptosis further strengthening the earlier 
argument that apoptosis is an intrinsic effect and does not involve death receptors.  This 
was also confirmed by RPA that showed no increase over controls in the expression 
patterns of various molecules involved in the extrinsic pathway.  It was however, 
interesting to note that following TMEV infection, there appeared to be a down 
regulation of molecules involved in the extrinsic pathway such as Fas and RIP.  
 Calpain has been implicated in the induction of apoptosis in neurons in case of 
Multiple Sclerosis (MS) (223) as well as in experimental allergic encephalitis (EAE) 
(221, 222, 224).  Several factors can lead to the activation of calpain, which is normally 
held in its proenzyme form by binding of the inhibitor – calpastatin (CAST) (161).  One 
of the ways by which calpain activation occurs is by its degradation of CAST by active 
caspase-3.  In addition, Ca2+ influx can also induce activation of calpain. This occurs due 
to changes in plasma membrane permeability or breakdown of cytoskeletal elements.  
Once activated, calpain, can further the apoptotic process initiated by caspase-3 as both 
caspase-3 and calpain share several substrates.  Some of the common substrates include 
PARP and cytoskeletal elements such as fodrin and spectrin.  Calpain had earlier been 
known to mediate only necrotic death and the ability for calpain to carry out cell death 
through apoptosis was first demonstrated in thymocytes (230).  Calpain can thus signal 
for both apoptosis and necrosis and unlike caspase-3 is not unique to one cell death 
process (248). The ability of calpain to signal for both apoptosis and necrosis may 
explain some of our earlier findings where the CVE infected with TMEV were initially 
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apoptotic, but very rapidly proceeded to secondary necrosis.  Our findings do not show 
any increased expression of apoptotic proteins by GDVII as compared to BeAn.   
 Calpain related apoptotic activity has been well documented in neural cell death 
associated with cerebral ischemia, Alzheimer’s disease (AD) (209) and Parkinson’s 
disease (PD) (19).  However, in the case of viral infections, calpain has only been 
implicated in reovirus infections of L929 cells (48) and neurons and in HIV infection of T-
lymphocytes (215).   
 The role for calpain-mediated cell death in TMEV infections is very interesting 
because of the association with apoptosis in MS and EAE.  The pathway of apoptosis 
induction in TMEV pathogenesis has been not clearly understood.  Neurons are very 
sensitive to Ca2+ level changes and thus can undergo apoptotic cell death involving 
calpain.  Similarly Ca2+ plays a very important role in the maintenance of the BBB and 
thus Ca2+ can be expected to play an important role in the induction of apoptosis in CVE, 
which form the BBB.    
 In summary, our data suggests a role for Ca2+ and calpain in the induction of 
apoptosis in CVE infected with BeAn and GDVII.  There is early activation of caspase-3 
but most of the effects on the nuclear components as well as cytoskeletal elements appear 
to be mediated in part by the activation of calpain.  This needs further characterization by 
studies using calpain inhibitors. 
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CHAPTER IV
INDUCTION OF APOPTOSIS IN BRAIN MICROVESSELS FOLLOWING
INTRA-PERITONEAL INFECTION WITH TMEV
INTRODUCTION
Neurotropic viruses employ a variety of methods to enter the central nervous
system (CNS) from their peripheral sites.  Rabies virus (45) and Herpes Simplex virus
(HSV)(167) are prototypes of viruses that enter the CNS through peripheral nerves.
Several other viruses such as arboviruses (51), human immunodeficiency virus (HIV)
(33) and measles virus (41) enter the CNS through the hematogenous route and infection
of the cerebrovascular endothelial cells (CVE). The human polyoma virus-JC virus that
causes Progressive Multifocal leukoencephalopathy (PML) is believed to use B cells as a
‘Trojan horse ’ to traverse the blood brain barrier (BBB) (79).
 Theiler’s murine encephalomyelitis virus (TMEV) is a Picornavirus that enters
the CNS occasionally following natural infection of the gut. CNS is a rare event
resulting in a biphasic disease in susceptible strains of mice that leads to an
inflammatory demyelinating disease.  The route of entry of Theiler’s virus into the CNS
has yet to be determined.  Studies suggest that TMEV enters the CNS through retrograde
axonal transport (146, 198), or by replication within cells of the BBB (119, 250, 251,
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259) or through infected macrophages (37, 129). There is considerable evidence pointing
to the role of BBB in the transport of TMEV into the CNS.
Much of the work on TMEV has been studied following intra-cranial inoculation
of TMEV.  Studies by Ha Lee et al. (73), indicate that following oral infection of
neonatal mice with TMEV, the route of entry of virus into the CNS most likely involves
viremia and spread via the blood stream. Previous studies have indicated that CVE are
permis!ive to TMEV infection both in vivo (259) and in vitro (251). Studies as early as
1988 by Zurbriggen and Fujinami (259) showed the involvement of CVE following
intracranial (i.c) inoculation of TMEV in nude mice.  Viral RNA could be demonstrated
in blood vessels near the lesions as well as in unaffected regions of the brain.  In
addition, earlier studies by Rodriguez et al. (202) reported an increase in the major
histocompatibility complex class II  (Ia) antigen expression on glial cells and endothelial
cells following TMEV infection intracranially.
Several other neurotropic viruses are capable of entering the CNS by replication
within the CVE. The disruption of the BBB appears to be a crucial event in the
development of the disease.  Many of the viruses that have been shown to cause
demyelination in animals also infect CVE.
In the case of HIV (33, 220) and SIV (4), in addition to replication in the CVE,
these viruses have been documented to induce apoptosis in CVE.  Induction of apoptosis
in CVE has been demonstrated in very few instances in viral infections of the CNS.  But
the evidence is compelling and this could lead to a breach in the BBB and allow for
inflammatory cells and more virus to gain access to the CNS and mediate damage.  In
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this study, we report for the first time induction of apoptosis in CVE following intra-
peritoneal infection of susceptible mice (SJL/J) with TMEV.  Induction of apoptosis was
demonstrated by TUNEL staining and by electron microscopy.
MATERIALS AND METHODS
Virus
The BeAn 8386 strain was obtained from Dr. Howard L. Lipton (Northwestern
University, Evanston, IL).  The virus was grown in BHK-21 cells, and the culture
supernatant containing infectious virus was aliquoted and stored at –70C before use.
The viral titer was determined by plaque assay on BHK-21 cells (206).
Infection of mice
Fifteen 4 –week old SJL/J mice were infected intra-peritoneally (i.p) with 5x104p.f.u. of
BeAn strain of Theiler’s virus in 100µl volume.  The mice were sacrificed on days
1,3,7,10,14 days post infection.  As a positive control, 3 mice were infected intra-
cranially (i.c) (under isoflurane anesthesia) and sacrificed at day 7 post-infection.  As
negative control, 3 mice were injected i.p with phosphate buffered saline (PBS).  At the
respective time, the mice were euthanized with pentobarbitone (150mg/kg i.p) and
perfused with PBS and 10% formalin intracardially.  The brains were fixed in 10%
formalin at room temperature overnight and embedded in paraffin.   Serial sections of
5µm each were cut and stained with haemotoxylin and eosin to examine inflammation or
TUNEL staining was performed to detect apoptosis.
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TUNEL staining
Fragmented DNA was detected in situ by the TdT mediated dUTP nick-end labeling
(TUNEL) staining method.  Paraffin-embedded 5-µm-thick sections were prepared for
the TUNEL method, which employed a commercially available kit (ApopTag Kit,
Intergen, Norcross, GA) following the manufacturer's instructions. Briefly,
deparaffinized sections were digested with proteinase K (20 mg/ml) for 15 min, and
endogenous peroxidase quenched with 2% H2O2 for 5 min. The sections were incubated
with TdT and a mixture of digoxigenin-labeled nucleotides for 60 min. This was
followed by incubation with anti-digoxigenin-peroxidase for 30 min, and color
development with H2O2–diaminobenzidine (DAB) for 3-6 min. Then, the slides were
counter stained with eosin for 30 sec and cover slipped. For positive controls, specimens
of mouse testes tissue were used. In these specimens, apoptosis was seen which showed
typical chromatin fragmentation labeled with TUNEL. Negative controls were
performed by omission of TdT enzyme from the incubation buffers.
Electron microscopy
One 4-week old SJL/J mouse was infected with BeAn i.p as previously described and
sacrificed at day 15 post-infection.  One mouse was used as a negative control and was
injected with PBS as previously described.  The brains of the sacrificed mice were
collected and fixed in paraformaldehyde/gluteraldehyde fixative in 0.1 M Cacodylate
buffer. The preparation of material for electron microscopy was a modification of the
method by Kalt and Tandler (106).  Tissues were post-fixed in 1% osmium tetraoxide,
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dehydrated in a series of 10-100% ethanol and embedded in epoxy resin (Araldite 502).
This was followed by polymerization in an oven for 2 subsequent steps, one at 45C for
24h and another at 60C for 24h.  Ultra thin sections (70-90 nm) were prepared using a
Ultrotome type 4802A ultramicrotome, stained with lead citrate uranyl acetate.  The
sections were examined and photographed using a Zeiss 10CA transmission electron
microscope at 80kV on Kodak Electron Microscope Film 4489.
RESULTS
TUNEL staining
TUNEL-positive cells were detected in SJL/J mice infected i.p with BeAn virus (Fig.
31).  Extensive apoptosis was detected in the positive controls, where BeAn was
introduced i.c to the mice.  No TUNEL-positive cells could be detected in PBS-treated
control mice. Following i.p inoculation of the virus, TUNEL-positive cells could be
detected after day- 7 post-infection.  The majority of the TUNEL-positive cells appeared
to be CVE cells surrounding blood vessels.  The distribution and identity of TUNEL-
positive cells following i.p or i.c inoculation was different. Very few TUNEL-positive
CVE could be detected following i.c infection of the mice.  The cells undergoing
apoptosis in these samples appeared to be neurons and astrocytes.   The number of CVE
undergoing apoptosis following i.p inoculation of the virus increased from days 7 post-
infection and by day 14 post-infection, other TUNEL-positive cells could be detected
surrounding blood vessels.   The blood vessels in the hippocampus had the most number
of apoptotic nuclei following i.p inoculation of the virus.  In case of the i.c inoculated
mice, the distribution of apoptotic nuclei was more widespread.
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FIG. 31.  TUNEL staining of brain section of SJL/J mice following
BeAn infection.  SJL/J mice were with either, inoculated with PBS
intraperitoneally for 7 days (A), infected intraperitoneally with 106 pfu of
BeAn for 7days (B), or infected  intraperitoneally with 106 pfu of BeAn for
14 days (C).  Note that TUNEL positive nuclei can only be observed in
BeAn infected  mice.  TUNEL cells appear to be CVE cells.  No other cell
type appears to be undergoing apoptosis following  ip inoculation of the
virus.
A B C
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Electron microscopy 
Figure 32 shows evidence for apoptosis in CVE following i.p infection of TMEV at 15 
days post-infection.  Electron microscopic studies reveal ultra-structural details 
characteristic of apoptosis in CVE surrounding blood vessels in the hippocampus region.  
Signs of apoptosis include condensation of nucleus, loss of organelles, cell shrinkage, 
collapse of the lumen.  There is edema surrounding these CVE undergoing apoptosis.  In 
some instances pericytes are evident, and these have been reported to have a function in 
endothelial proliferation and they also express phagocytic function (237).  In contrast, 
there are no signs of CVE undergoing apoptosis in control mice treated with PBS.  There 
is no collapse of the lumen, or nuclear condensation and loss of organelles.  In addition, 
no edema is observed surrounding these healthy CVE in the hippocampus.    
DISCUSSION 
 In this study, we report for the first time, evidence for the induction of apoptosis 
in CVE following i.p infection of TMEV in SJL/J mice.  Apoptosis in CVE was 
demonstrated by TUNEL staining and electron microscopy.  Apoptotic nuclei were first 
evident at 7 days post-infection and increased in number from day 14.  The distribution 
of apoptotic cells was different in mice infected with TMEV by i.p or i.c routes. Most of 
the damage in mice infected with TMEV i.p appears to be in the hippocampus region.  
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FIG. 32.  Electron micrographs of brain sections of SJL/J mice following
ip inoculation of BeAn. SJL/J mice were either inoculated with, PBS
intraperitoneally (A) or with 106 pfu of BeAn intraperitoneally (B) for 15 days.  
Normal blood vessels are found in sham infected mice, whereas in the virus-
treated mice, lumen of the blood vessels in the brain are collapsed.  CVE cells 
lining the blood vessels show signs of apoptosis characterized by shrinkage of 
cells, nuclear condensation, loss of organelles.  The areas surrounding the 
affected CVE are edematous indicating signs of loss of permeability barrier at 
this site.
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Whereas in the i.c infected mice, the areas of the brain undergoing apoptosis
appear to be more widespread.  Following i.c injection of TMEV, the cells undergoing
apoptosis appear to be neurons and some astrocytes. There is no evidence for apoptosis
in CVE following i.c infection of TMEV.
Electron microscopic studies provide further evidence for apoptosis in CVE
following i.p injection with TMEV.  Induction of apoptosis in CVE is accompanied with
recruitment of pericytes and extensive edema surrounding the affected blood vessels.
Blood-brain barrier (BBB) is a function of the endothelial cells. They maintain
homeostasis in the brain by regulating the flow of proteins and fluids into the brain.  Any
change in the autoregulatory process can increase CVE permeability and produce brain
edema because capillaries dilate from increased luminal pressure, widening of inter-
endothelial tight junctions and increase in transcapillary fluid filtration.  Cells
undergoing apoptosis characteristically shrink in size and this may cause widening of the
inter-endothelial tight junctions and permit edema in the areas surrounding the blood
vessels.
The difference in the distribution of apoptotic nuclei following i.p or i.c infection
of TMEV may be related to the fact that neurotropism and distribution of a particular
virus depends on the site of inoculation.  For example, in case of the NSW strain of
influenza virus, following i.p injection, the virus spreads by viremia (193).  The viral
antigens are then demonstrated in meninges, choroid plexus, ependymal cells and in
perivascular locations suggesting entry through the BBB.  It does not infect neurons
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through this route. However, following intra-nasal inoculation of the virus, the virus
spreads through nerves and viral antigens could be demonstrated in the neurons of the
olfactory bulbs, trigeminal ganglion and the brain stem.
Following TMEV infection, there is evidence for involvement of CVE in the
pathogenesis of the virus and CNS invasion.  CVE cells were shown to be permissive to
TMEV in vitro.  Studies by Welsh et al. (251) demonstrate that BeAn replicated to
similar levels in cloned CVE from both susceptible and resistant strains of mice.  The
levels of replication in these CVE were comparable to BHK-21 cells.  In addition,
persistent infection with TMEV could be established in these CVE.  Persistent infection
of CVE could provide a reservoir for infectious viruses, which could lead to re-infection
of the CNS.  This could result in characteristic perivascular infiltration of immune cells
seen in TVID and cause recurrent episodes of demyelination (21). Several other viruses
that have been implicated in the etiology of MS have been found to replicate in CVE.
These include measles virus (MV)(41), and HSV-1 (25).
Studies by Zurbriggen and Fujinami (259) showed the involvement of CVE
following i.c inoculation of TMEV in nude mice.  Viral RNA could be demonstrated in
blood vessels near the lesions as well as in unaffected regions of the brain.  They could
demonstrate viral RNA but not viral antigens in CVE suggesting either a restriction at
the level of RNA replication or a difference in the sensitivities of the immuno-
histochemistry reaction.  This finding challenged the earlier belief of intra-axonal
dissemination of the virus to the spinal cord.  This also shed some light on the mode of
transmission of TMEV from the gut to CNS in the natural infection.
102
Studies by Ha lee et al. (73) have showed that oral infection with TMEV by the
per os (p.o) route, usually causes asymptomatic enteric infection in adult immuno-
competent mice.  Neonatal mice were more susceptible to infection through this route
and showed first signs of disease 7-9 days post-infection (p.i) and this was accompanied
by death 12-19 days p.i.  Mice that were older than 7 days showed no signs of the
disease and all survived.  In the neonatal mice, the evidence pointed to the involvement
of BBB in the transmission of the virus to the CNS.  However, no virus was detected in
the CVE from these mice and this had been attributed to the lack of sensitivity of
procedures in detecting small amounts of the virus.  They provide arguments against a
neural spread of the virus from the gastro-intestinal tract as well as from organs such as
the spleen and lymph nodes where they could be seeded following primary viremia.
Studies by Inoue et al. (84) showed that fibrin deposition in spinal cord vessels is
significantly increased in i.c treated SJL/J at 30 days p.i.  Batroxobin, a thrombin like
defibrinogenating enzyme could reduce deposition of fibrin and also development of
clinical symptoms suggesting that extravasation of fibrin could have detrimental effects.
Fibrin is believed to set off a cascade that opens up the BBB and also leads to the influx
of inflammatory cells into the CNS.
Earlier studies by Rodriguez et al. (201) reported an increase in the major
histocompatibility complex class II  (Ia) antigen expression on glial cells and endothelial
cells following TMEV infection. This can be deduced as the ability of the virus to
replicate in these cells and thus stimulate antigen-presenting functions.  Other viruses
such as Coronavirus (147) and Sindbis virus (SV) (242) can also stimulate Ia production
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in astrocytes and microglial cells respectively and this may be linked to their
pathogenesis.  In case of SV, some endothelial cells also showed Ia antigen expression
and this suggested a role for CVE in the pathogenesis of the virus. Measles virus induces
Ia production on astrocytes (148).
Several viruses can infect CVE and mediate damage by causing cytopathic
effects in the CVE, by up-regulation of several adhesion molecules and recruitment of
inflammatory cells or by induction of apoptosis in CVE.  Studies on the pathogenesis of
Semliki Forest virus (SFV) have indicated the involvement of the BBB in the spread of
the disease to the CNS (56, 228).  SFV serves as another model to study MS.  Various
studies indicate that SFV is capable of infecting CVE and inducing the upregulation of
several adhesion molecules such as ICAM-1 (228).
 Neurovirulent simian immunodeficiency virus (SIV)(144) and human
immunodeficiency virus (HIV) (33, 220) replicate productively in the CVE both in vivo
and in vitro.  In SIV infected monkeys, there is apoptosis of neurons, glial cells and
endothelial cells.  Virus replication in CVE could not only provide a mechanism for
initial viral entry into the CNS, but virus-induced changes in CVE could potentially alter
the integrity and function of the BBB.  These virus-induced alterations could include
alterations in the expression of adhesion molecules and thus promote the influx of
inflammatory cells into the CNS.  These alterations could also result in increased virus
load in the CNS. Intranasal inoculation of avian influenza virus A can also induce
apoptosis in vivo in vascular endothelial cells of the liver, kidney and brain (85) of the
chicken.  This was indicated by cerebral leakiness by detecting fibrinogen in the
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extravascular space of the brain in areas with virus antigen. Viral antigens and nucleic
acid could be detected in blood vessel walls in vivo and the virus infected CVE in vitro.
Viruses are normally excluded from entering the CNS in significant amounts.
Introduction of several viruses through the general route, could lead to CNS involvement
following a breach in the BBB by treatment with detergents, lipopolysaccharide or by
mechanical injury (114, 142). Several viruses themselves can cause injury to the BBB
and result in the infection of CNS through replication in the CVE (41, 228).
Thus in the present study, we provide preliminary evidence for the induction of
apoptosis in CVE following i.p injection of TMEV in SJL/J mice.  Induction of
apoptosis in cells forming the BBB could provide a route for further entry of virus and
inflammatory cells into the CNS.  This study requires further characterization such as
co-localization of viral antigens and TUNEL staining to indicate that induction of
apoptosis in the CVE is a direct effect of the virus and not a result of soluble factors such
as cytokines. Also, breakdown in the BBB needs to be demonstrated by methods such as
fibrin staining.
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CHAPTER V            
                                            
DISCUSSION AND CONCLUSIONS 
  
CONCLUSIONS 
 Relapses in Multiple Sclerosis (MS) are associated with viral infections (9, 225), 
but it is not known how viral infections modulate this autoimmune demyelinating disorder.  
Blood-brain barrier (BBB) damage caused by viral infection is one possible mechanism, 
since increased BBB permeability is an early and possible crucial event in the 
pathogenesis of new lesions in MS (109).  Furthermore, some viral infections are known to 
cause vascular permeability changes.  Vascular injury is a central feature of some 
hemorrhagic fevers (43) and BBB damage has been shown during human 
immunodeficiency virus (HIV) encephalitis (185) and uncomplicated measles virus (MV) 
infection (74).   
 The evidence for BBB damage in MS is compelling but whether this damage is 
mediated by virus is undetermined.  As early as 1964, BBB damage had been 
demonstrated in autopsy of MS patients (27).  Evidence such as accumulation of fibrin in 
perivascular areas of the brain, suggest microvessel permeability (38) and Van der Maesen 
et al. suggest that cerebrovascular endothelial cells (CVE) transiently express MHC II 
indicating immune modulatory functions (244).  More recently, there has been the 
demonstration of abnormal tight junctions in active lesions and in normal appearing white 
 106 
matter in MS patients (191) and Minagar et al. (159) have shown the increase in 
endothelial cells microparticles (EMP) during episodes of MS.  EMPs are believed to be 
released following activation of endothelial cells or following apoptosis of CVE.  Certain 
adhesion molecules such as Vitronectin receptor and β2 integrins are increased on 
endothelial cells in MS (227) and recently these integrins have been suggested to play a 
role in signaling for macrophage-mediated removal of apoptotic cells.  In addition, anti-
endothelial cell antibodies and circulating immune complexes have been found in MS 
(235).  Anti-endothelial cell antibodies were elicited in another auto-immune disease – 
systemic lupus erythematosus (SLE) (35) and this connection between the two auto-
immune diseases may be important. 
 It is largely unknown whether increased vascular permeability during viral 
infections is caused by viral replication in the CVE, virus-induced cytokines, anti-
endothelial cells antibodies raised during viral infections or other yet unknown 
mechanisms.  BBB is a function of CVE and any damage to CVE can have a profound 
influence on the inflammatory mileu of the brain.  BBB normally inhibits viral infection of 
the central nervous system (CNS) and may also deter viral clearance from the CNS.  
 Several viruses infect endothelial cells in culture and damage them by a variety of 
mechanisms.  Semliki forest virus (SFV)(56), HIV (33) and MV (41) enter the CNS by 
infection and replication within the CVE.  SFV is believed to mediate damage to the BBB 
in addition by the expression of adhesion molecules such as ICAM-1 following replication 
within the CVE (228).  Following dengue virus (DV) infection, antibodies against the 
virus cross-react with endothelial cells and mediate damage and lead to vascular leakage 
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(132).  In the case of Japanese encephalitis virus (JEV), replication of the virus within 
CVE and a macrophage-derived neutrophil chemotactic factor (MDF) are believed to lead 
to permeability of the BBB (149).  Some viruses such as HIV (220), simian 
immunodeficiency virus (SIV)(4), influenza A virus (85) are capable of replicating with 
CVE and inducing apoptosis in these cells.  The effect of induction of apoptosis in CVE 
following infection by the virus has not been defined.  Apoptosis in CVE in vitro has also 
been documented following treatment with oxyhemoglobin (172) and bilirubin (5).   
 Apoptosis in virus-infected cells do not greatly differ from other types of apoptosis 
but the viral infection may leave additional marks on the cells.  Virus-infected cells 
undergoing apoptosis show heightened signs of apoptosis and they exhibit severe 
chromatin condensation around the periphery of the nucleus and active blebs that remain 
intact.  But in some cases, the apoptosis may be so intense that insufficient numbers of 
cells are present to engulf the apoptotic cells bearing foreign viral antigens or the ultimate 
release of apoptotic bodies leading to increased inflammatory response.  Induction of 
apoptosis itself may present as a function of the host defense against virus or may be 
initiated by the virus.  Most DNA viruses are capable of suppressing apoptosis and carry 
anti-apoptotic genes as they require nuclear integrity to complete replication (116). In this 
case, induction of apoptosis following viral infection is a result of the host cell defense to 
curtail virus replication.  However, most RNA viruses have relatively short replication 
time and have cytoplasmic sites of replication and in this case, the induction of apoptosis 
is beneficial to the virus and could in fact help in the release of non-lytic viruses.   
Apoptosis does not usually recruit an active inflammatory response.  However, apoptosis 
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could ultimately result in secondary necrosis and the compromise of the plasma membrane 
releasing the virus as well as other toxic elements thus recruiting an active immune 
response, which may be detrimental at sites such as the brain, where post-mitotic neurons 
are irreplacable.   
 Theiler’s murine encephalomyelitis virus (TMEV) is a Picornavirus that is capable 
of inducing a demyelinating disease similar to MS in susceptible strains of mice. 
Following the natural course of infection, CNS invasion, which is a rare event is achieved 
in a small majority of mice and can lead to a biphasic demyelinating disease -Theiler’s 
virus-induced demyelination (TVID).  The virus can be inoculated through a variety of 
routes such as intra-cranial (i.c), intra-peritoneal (i.p) and intra-nasal (i.n) routes.  The 
chronic phase of the disease following i.c inoculation of the virus has been extensively 
studied due to its similarity at this stage to the disease pattern in MS especially with 
relation to the auto-immune components and inflammatory response.  However, the acute 
phase of the disease has not been studied thoroughly.   
 There is considerable evidence pointing to the role of the BBB in the entry of the 
virus from systemic circulation to the CNS following natural infection.  Following, oral 
route of inoculation of the virus, the entry of the virus into the CNS has been suggested via 
the BBB following viremia (73).  CVE have been reported to be permissive to TMEV both 
in vitro (119, 251) and in vivo (259).  Studies by Rodriguez have demonstrated an increase 
in MHC II antigen (Ia) on glial cells and CVE following TMEV infection i.c (202).   
 Like other members of Picornaviridae, TMEV is also capable of inducing 
apoptosis in a variety of cells.  Members of Picornaviridae capable of inducing apoptosis 
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include coxsackie B virus (31), enchepalomyocarditis virus (EMCV) (254) and PV (44, 
69, 139).  PV is unique in its ability to both induce as well as inhibit apoptosis depending 
on the permissivity of the cell type (238).  TMEV can induce apoptosis in a variety of cell 
types including neurons (10, 241), oligodendrocytes (241), astrocytes (180, 256), and 
macrophages (92-94).  Whether the induction of apoptosis in these cells in vivo is 
responsible for the pathogenesis of the virus has yet to be determined.   Our study adds 
CVE to the list of cells that are capable of undergoing apoptosis following TMEV 
infection. This is the first report of the only permissive cell type, apart from neurons, that 
undergoes apoptosis following TMEV infection.  The ability of TMEV to induce apoptosis 
has been attributed to the permissivity of the cells to the virus in previous reports (95).  
TMEV-induced apoptosis has been reported as a result of virus infection since virus that is 
inactivated by UV-irradiation fails to induce apoptosis (95) and our studies confirms this 
in cloned mouse CVE.  The GDVII strain is much more efficient at inducing apoptosis 
than the TO strains and earlier reports have demonstrated the role for an anti-apoptotic 
protein -L* protein in the persistence of the TO strains (63).   
 Our studies demonstrate for the first time the induction of apoptosis in CVE both in 
vitro and in vivo following i.p inoculation of the virus.  This could be crucial for the 
pathogenesis of the virus since the induction of apoptosis in CVE could lead to damage to 
the BBB as seen in other viral infections and allow for inflammatory cells and more virus 
to enter the CNS.  There appeared to be no difference in the induction of apoptosis in the 
CVE derived from two genetically different mice (SJL/J and BALB/c) and we could thus 
infer that ability to mount inflammatory response and subsequent steps may be more 
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crucial in the pathogenesis of the virus.  GDVII induced heightened apoptosis in CVE 
following infection as demonstrated by several studies.  However, the protein profile did 
not suggest an overt activation of pro-apoptotic genes following GDVII infection.   
 Studies reported herein, with Annexin V staining, Hoechst staining and caspase 
staining provide insights into the timing of induction of apoptosis, although more 
experimentation is required.  Endothelial cells are very susceptible to the induction of 
apoptosis following serum deprivation due removal of growth factors present in the serum 
(81, 194). However, our studies indicate that CVE are not highly susceptible to apoptosis 
induced by 3 days of serum deprivation and this would not hinder the observation of 
apoptosis following TMEV infection.  Like other RNA viruses, increasing the dosage of 
virus increased the induction of apoptosis and this appeared to be related to cytopathic 
effects (CPE) shown by the virus. Most viruses belonging to Picornaviridae have the 
ability to induce CPE in the cell types they infect and thus has been used as an easy marker 
for virus replication in cell culture following PV infection (143).  CPE has been 
characterized by cell rounding and nuclear condensation, followed by shrinkage and 
detachment of cells from their support.  Picornaviruses, with the possible exception of 
hepatitis A virus (HAV) (34, 75), induce cell alterations that culminate ultimately in cell 
death.  The earlier finding that CPE caused by the virus could result in death of the cell is 
challenged by the finding that apoptosis can also lead to picornavirus-related cell death.  
The mechanisms of CPE and apoptosis are different.  CPE consists of nuclear alterations 
and  restructuring of cellular membrane that are involved in efficient viral replication.  
Apoptosis, on the other hand is a cellular suicide program and may be triggered by many 
 111 
stimuli including viral infections.  In picornavirus-infected organs of human or animals, 
cells can be found showing characteristics of either CPE or apoptosis.  It is an open 
discussion whether the outcome of an infection depends on the balance between apoptosis 
and viral-mediated cell killing.  Our studies indicate that increasing the titer of the virus, 
increased CPE as well as apoptosis and clumps of cells detached due to CPE were shown 
to be apoptotic with Hoechst staining.   
 Studies using caspase-3 and mitochondrial activation staining, indicate the 
activation of caspase-3 occurs as early as 3 hr in CVE infected with TMEV.  This occurs 
earlier than nuclear condensation, which can be determined by Hoechst staining.  The 
reduction in the apoptotic nuclei following incubation of CVE with pan-caspase inhibitors 
indicate that caspase-3 is possibly a very early event in the death of the cell. Whether this 
is a result of host defense against the virus or triggered by virus itself cannot be 
ascertained.  The indication of mitochondrial activation following caspase-3 activation, but 
before condensation of the nucleus, indicates the role of mitochondria in the cascade of 
events.  The involvement of mitochondria related proteins such as bax, bcl-2, bak, bid and 
cytochrome-c needs to be determined.  This could be crucial to our studies as the 
involvement of Ca2+ in our system is definite.   
 Consistent with other findings, inactivation of the virus following UV-irradiation 
did not induce apoptosis in CVE thus enforcing the fact that live virus was required and 
apoptosis was a result of intrinsic factors.  Several viruses such as hepatitis B virus (77) 
and SIV (98) can induce apoptosis by the recruitment of Fas and other surface molecules.  
This does not appear to be the case with TMEV.  Interestingly, in case of TMEV infection 
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of CVE, there appeared to be a down regulation of surface molecules involved in 
apoptosis such as Fas and RIP. HIV, which is known to be a strong inducer of apoptosis in 
several cell types is believed to down regulate Fas in lymph nodes of patients with 
HIV(249).  The importance of this finding is not determined.  Down regulation of Fas has 
mostly been attributed to the ability of the virus to inhibit apoptosis and this does not 
appear to be the case in CVE infected with TMEV.   
 Electron microscopic studies on CVE infected with TMEV indicate that following 
infection, the CVE showed signs of apoptosis clearly indicated by signs such as cell 
shrinkage, surface blebbing, nuclear condensation and loss of organelles, but the relative 
preservation of the cell membrane.  But by 24h following infection, the cells appeared to 
rapidly show signs of secondary necrosis.  Classically, apoptotic cells package into 
apoptotic bodies, which are engulfed by neighboring cells or by macrophages, but 
occasionally, cells are known to progress into secondary necrosis following viral 
infections.  This finding by electron microscopy is supported by Annexin V data, which 
shows passage of cells into secondary necrosis by display of phosphotidyl-serine early in 
apoptosis and staining with propidium-iodide in addition later indicating cell membrane 
compromise.  This may also be explained by our finding later that calpain is involved at a 
later stage in the apoptotic process following TMEV infection of CVE.   
 Calpain is known is to trigger for apoptosis as well as necrosis and has been a 
strong candidate for studies in apoptosis in MS as well as experimental allergic 
encephalomyelitis.  We propose for the first time the involvement of calpain in TMEV 
infection.  Calpain activation is central to the apoptotic process in neurons and increased 
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calpain activity was observed in reactive astrocytes, activated T cells, and activated 
mononuclear phagocytes in and adjacent to demyelinating lesions (223) in MS but has 
never been demonstrated in CVE following viral infections.  The involvement of calpain 
in the induction of apoptosis could be crucial as this could lead to loss of membrane 
integrity and thus could amplify the inflammatory response at the site of infection instead 
of curtailing inflammation due to apoptosis.   
 In vivo studies following i.p inoculation of TMEV has been attempted very 
infrequently. Considering the enteric source of infection, this route of infection would be 
ideal to study a more naturalistic model of infection and route of entry of virus into the 
CNS.  Our studies with i.p inoculation of the virus indicate the alterations in CVE of the 
hippocampus area.  CVE in this area appeared to be undergoing apoptosis and large areas 
of edema were evident surrounding blood vessels indicating increased permeability.  The 
lumen of the blood vessels appeared collapsed and the CVE appeared to be shrunken but 
the cell membrane appeared intact.    
 Thus with the evidence provided by the studies, we propose the following theory. 
Following natural enteric infection of mice, TMEV enters the CNS following general 
viremia and primary seeding in other organs such as spleen and liver and lymphoid 
tissue.  At the BBB, TMEV enters and replicates in CVE, and induces CPE as well as 
apoptosis in them.  The two processes might be mutually dependent or totally exclusive 
events and this cannot be determined at this moment.  Activation of caspase-3 is central 
to the apoptotic process, but unlike most processes, caspase-3 activation is followed by 
calpain activation and this leads to nuclear breakdown events as well as cytoskeletal 
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changes.  Induction of apoptosis in areas such as the BBB in the brain could have a 
variety of effects.   
 One of the hallmarks of apoptosis is cell shrinkage and considering the 
characteristics of the CVE that form the BBB, this could be crucial. Other reports such 
as osmotic shrinkage in a hypertonic environment in the BBB could result in cell 
shrinkage and widening of the tight junctions (165, 210).  These changes can cause 
increase in CVE permeability and produce brain edema as capillaries dilate from 
increased luminal pressure.  Similar effects due to apoptosis of CVE can be 
hypothesized.   
 Unlike necrosis, apoptosis leads to cell death with minimal inflammatory 
response.  Our finding of the involvement of calpain in the apoptotic process in CVE 
might result in the compromise of the cell membrane and thus release toxic cell 
components into general circulation thus eliciting a huge inflammatory response.  
Apoptotic cells display phosphotidyl-serine on their surface, thus recruiting 
macrophages to the site, but involvement of calpain may mediate a much higher 
inflammatory response.  Studies with human umbilical vein endothelial cells (HUVEC) 
have shown that endothelial cells induced to become apoptotic by oxidative damage, 
result in the recruitment of complement (160).  CVE undergoing apoptosis could also 
cause similar changes and result in inflammation at the site. Thus, unlike common belief, 
apoptosis of cells can also cause increased inflammation like necrosis.   
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FUTURE DIRECTIONS 
The present study provides preliminary evidence for the involvement of apoptosis of 
CVE in the pathogenesis of TMEV.  This model needs to be strengthened by the 
following studies: 
1. Determination of virus load in various organs following i.p inoculation over time.  
This will increase our understanding of TMEV invasion of the CNS.  Some of 
the proposed organs to be studied include spleen, heart, and liver.  It is believed 
that TMEV infection naturalistically involves a viremic stage.  Viral load in the 
blood at various times following i.p infection is proposed to understand this 
viremic stage better. 
2. Determination of virus distribution in the brain following i.p inoculation and co-
localization studies for virus and apoptosis.  Employing methods such as fibrin 
deposition should be undertaken to determine extent of blood-brain barrier 
damage.   
3. Determination of genes involved in apoptosis at the BBB and the use of calpain 
and caspase inhibitors to prevent the apoptotic effects of the virus.   
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